UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 FORM 10-Q 

 

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2020March 31, 2021

 

Commission file number: 000-12627

 

GLOBAL CLEAN ENERGY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 87-0407858
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification Number)
   
2790 Skypark Drive, Suite 105 Torrance, California 90505
(Address of principal executive offices) (Zip Code)

 

  (310) 641-4234  
  (Registrant’s telephone number, including area code)  

 

Securities registered under Section 12(b) of the Act:

Title of Each ClassTrading SymbolName of Each Exchange on Which Registered
N/AN/AN/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes No

 

The number of shares of the issuer’s Common Stock, par value $0.001 per share, outstanding as of December 10, 2020May 17, 2021 was 358,499,606.38,765,194.

 
 
 
 

Part I. FINANCIAL INFORMATION

 

Item 1: Financial Statements

 

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 June 30, December 31, March 31, December 31,
 2020 2019 2021 2020
ASSETS (Unaudited) (Audited) (Unaudited) (Audited)
CURRENT ASSETS            
Cash and cash equivalents $3,870,499  $457,331  $3,119,063  $3,370,519 
Accounts receivable  96,061   143,823 
Restricted cash  3,296,514   —     11,855,532   12,943,222 
Inventories  22,942   22,942 
Inventory  903,504   846,197 
Investment in farming activities  265,976   —     745,843   404,258 
Prepaid expenses and other current assets  7,225,373   —     4,639,774   5,027,294 
Total Current Assets  14,681,304   480,273   21,359,777   22,735,313 
                
DEBT ISSUANCE COSTS, NET  840,211   500,000 
RESTRICTED CASH, NET OF CURRENT PORTION  20,763,986   22,668,984 
DEBT ISSUANCE COSTS  1,508,211   840,211 
RIGHT-OF-USE ASSET  67,103   82,450   73,867   51,611 
INTANGIBLE ASSETS, NET  5,768,012   2,501,592   4,125,482   4,180,746 
DEPOSITS  1,246,978   3,253,253 
PROPERTY AND EQUIPMENT, NET  124,918,910   —   
PRE-ACQUISITION COSTS  —     2,588,441 
LONG TERM DEPOSITS  586,812   628,382 
PROPERTY, PLANT AND EQUIPMENT, NET  170,028,718   138,972,675 
ADVANCES TO CONTRACTORS  19,440,631   —     16,000,000   16,000,000 
                
TOTAL ASSETS $166,963,149  $9,406,009  $234,446,853  $206,077,922 
                
LIABILITIES AND STOCKHOLDERS' DEFICIT                
CURRENT LIABILITIES                
Accounts payable and accrued expenses $3,418,303  $1,778,434 
Accrued compensation and related liabilities  2,432,474   2,055,167 
Accrued interest  3,096,990   1,734,527 
Accounts payable and accrued liabilities $30,257,909  $22,597,951 
Lease liabilities  68,053   82,882   74,911   52,653 
Notes payable including current portion of long-term debt, net  4,142,582   1,369,856 
Notes payable  3,436,499   4,198,113 
Convertible notes payable  1,697,000   1,697,000   1,413,500   1,697,000 
Derivative liability  —     24,767,000 
Total Current Liabilities  14,855,402   33,484,866 
Total Current Liabilities  35,182,819   28,545,717 
                
LONG-TERM LIABILITIES                
Mandatorily redeemable preferred equity of subsidiary  939,000     
Mandatorily redeemable equity instruments of subsidiary  7,193,000   5,123,000 
Long-term debt, net  16,320,831       17,353,088   16,155,138 
Long-term debt, net (credit facility)  76,045,162       174,426,075   146,769,225 
Asset retirement obligations  40,740,700   —   
Environmental liabilities  33,987,800   —   
Other liabilities  377,331   —   
        
Asset retirement obligations, net of current portion  16,548,318   17,762,977 
Environmental liabilities, net of current portion  20,120,764   20,455,938 
TOTAL LIABILITIES  183,266,226   33,484,866   270,824,064   234,811,995 
                
STOCKHOLDERS' DEFICIT                
Preferred stock - $0.001 par value; 50,000,000 shares authorized Series B, convertible; 13,000 shares issued and outstanding (aggregate liquidation preference of $1,300,000)  13   13   13   13 
Common stock, $0.001 par value; 500,000,000 shares authorized; 358,499,606 and 344,029,434 shares issued and outstanding, respectively  358,499   344,029 
Common stock, $0.001 par value; 500,000,000 shares authorized; 37,438,668 and 35,850,089 shares issued and outstanding, respectively  374,386   358,499 
Additional paid-in capital  36,994,168   31,259,365   37,702,003   37,139,854 
Accumulated deficit  (53,655,757)  (55,682,264)  (74,453,613)  (66,232,439)
Total Stockholders' Deficit  (16,303,077)  (24,078,857)  (36,377,211)  (28,734,073)
                
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $166,963,149  $9,406,009  $234,446,853  $206,077,922 

 

The accompanying notes are an integral part of these financial statements

 

 -1-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 For the three months For the six months For the three months
 ended June 30, ended June 30, ended March 31
 2020 2019 2020 2019 2021 2020
            
REVENUE  —     —     —     —           
Seed sales  94,645   —   
Cost of Goods Sold  (85,276)  —   
Gross Profit  9,369   —   
                        
OPERATING EXPENSES                        
General and Administrative  1,820,933   937,765   2,064,040   1,965,342   3,714,962   309,084 
Facilities expense  709,305       775,282       2,840,537   —   
Depreciation expense  27,031   —     27,031   —     25,670   —   
Amortization of intangible assets  95,023   61,306   156,330   122,613   89,030   61,307 
Preliminary stage acquisition costs  —     82,693   —     1,016,936 
Total Operating Expenses  2,652,292   1,081,764   3,022,683   3,104,891   6,670,199   370,391 
                        
OPERATING LOSS  (2,652,292)  (1,081,764)  (3,022,683)  (3,104,891)  (6,660,830)  (370,391)
                        
OTHER INCOME (EXPENSE)                        
Interest expense (net)  (759,225)  (89,546)  (939,173)  (180,075)  (710,162)  (179,948)
Other income  1,049   —   
Gain in derecognition of derivative liabilities  —     —     512,363   —     —     512,363 
Change in fair value of Class B Units  (851,231)  —   
Change in fair value derivative and finance charges related to derivative liability  —     1,318,000   5,476,000   (2,619,000)  —     5,476,000 
Total Other Income (Expense)  (759,225)  1,228,464   5,049,190   (2,799,075)
Total Other Income (Expense), net  (1,560,344)  5,808,415 
                        
NET INCOME/(LOSS)  (3,411,517)  146,690   2,026,507   (5,903,966)  (8,221,174)  5,438,024 
BASIC NET INCOME/(LOSS) PER COMMON SHARE  (0.01)  0.00   0.01   (0.01)  (0.23)  0.15 
DILUTED NET INCOME PER COMMON SHARE  (0.01)  0.00   0.00   (0.01)  (0.23)  0.08 
WEIGHTED AVERAGE SHARES OUTSTANDING  355,889,716   341,529,434   353,860,445   341,529,434 
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING  36,096,794   35,183,117 
DILUTED WEIGHTED-AVERAGE SHARES OUTSTANDING  355,889,716   633,198,762   639,971,915   341,529,434   36,096,794   64,077,486 

 

The accompanying notes are an integral part of these financial statements

 

 -2-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

(Unaudited)

 

         Additional    
 Series B Common Stock Paid in Accumulated  
 Shares Amount Shares Amount Capital Deficit Total
Balance at December 31, 2018  13,000  $13   341,529,434  $341,529  $30,669,220  $(43,890,445) $(12,879,683)
Share-based compensation from issuance of options and compensation-based warrants  —     —     —     —     43,008   —     43,008 
Exercise of stock options  —     —     —     —     —     —     —   
Net income for the quarter ended March 31, 2019  —     —     —     —     —     (6,050,656)  (6,050,656)
Balance at March 31, 2019  13,000  $13   341,529,434   341,529   30,712,228   (49,941,101)  (18,887,331)
Share-based compensation from issuance of options and compensation-based warrants  —     —     —     —     460,395   —     460,395 
Exercise of stock options  —     —     —     —     —     —     —   
Net income for the quarter ended June 30, 2019  —     —     —     —     —     146,690   149,690 
Balance at June 30, 2019  13,000  $13   341,529,434  $341,529   31,172,623   (49,794,411)  (18,280,246)
              
         Additional             Additional    
 Series B Common Stock Paid in Accumulated   Series B Common Stock Paid in Accumulated  
 Shares Amount Shares Amount Capital Deficit Total Shares Amount Shares Amount Capital Deficit Total
Balance at December 31, 2019  13,000  $13   344,029,434  $344,029  $31,259,365  $(55,682,264) $(24,078,857)  13,000  $13   34,402,944  $344,029  $31,259,365  $(55,682,264) $(24,078,857)
Share-based compensation from issuance of options and compensation-based warrants  —     —     —     —     25,614   —     25,614   —     —     —     —     25,614   —     25,614 
Exercise of stock options  —     —     8,177,315   8,177   63,419   —     71,596   —     —     817,732   8,177   63,419   —     71,596 
Net income for the quarter ended March 31, 2020  —     —     —     —     —     5,438,024   5,438,024   —     —     —     —     —     5,438,024   5,438,024 
Balance at March 31, 2020  13,000  $13   352,206,749   352,206   31,348,398   (50,244,240)  (18,543,623)  13,000  $13   35,220,676   352,206  $31,348,398  $(50,244,240) $(18,543,623)
                            
                  Additional         
  Series B   Common Stock   Paid in   Accumulated    
  Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance at December 31, 2020  13,000  $13   35,850,089  $358,499  $37,139,854  $(66,232,439) $(28,734,073)
Share-based compensation from issuance of options and compensation-based warrants  —     —     —     —     155,186   —     155,186   —     —     —     —     102,000   —     102,000 
Exercise of stock options  —     —     6,292,857   6,293   12,907   —     19,200 
Option grants for investment in subsidiaries  —     —     —     —     5,477,677   —     5,477,677 
Net loss for the quarter ended June 30, 2020  —     —     —     —     —     (3,411,517)  (3,411,517)
Balance at June 30, 2020  13,000  $13   358,499,606  $358,499   36,994,168   (53,655,757)  (16,303,077)
Shares issued upon reverse split to avoid fractional shares  —     —     1,793   19   (19)  —     —   
Conversion of note payable to shares  —     —     1,586,786   15,868   460,168   —     476,036 
Net loss for the quarter ended March 31, 2021  —     —     —     —     —     (8,221,174)  (8,221,174)
Balance at March 31, 2021  13,000  $13   37,438,668  $374,386  $37,702,003  $(74,453,613) $(36,377,211)

 

The accompanying notes are an integral part of these financial statements

 

 -3-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

 

 For the six months ended June 30, For the three months ended March 31,
 2020 2019 2021 2020
Operating Activities:                
Net Income/(Loss)  2,026,507   (5,903,966) $(8,221,174) $5,438,024 
Adjustments to reconcile net loss to net cash used in operating activities:                
Share-based compensation  180,800   503,403   102,000   25,614 
Depreciation and amortization  181,411   —     114,700   61,306 
Accretion of asset retirement liabilities  245,000   91,372 
Gain on settlement of liabilities  (512,363)  122,613   —     (512,363)
Change in fair value of derivative liability  (5,476,000)  2,619,000   —     (5,476,000)
Change in fair value of Class B Units  851,231   —   
Amortization of debt discount  745,648       597,390   —   
Changes in operating assets and liabilities:                
Accounts receivable  47,762   —   
Inventories  (57,307)  —   
Farming activities  (265,976)  —     (341,585)  —   
Prepaid expenses  (2,900,691)  —     387,520   —   
Deposits and other assets  (1,493,725)  —     41,570   —   
Accounts payable and accrued expenses  1,639,869   882,307 
Accrued compensation and related liabilities  377,307   (21)
Interest payable  1,631,553   181,057 
Other liabilities  377,331   —   
Accounts payable and accrued expenses, interest and compensation  3,146,978   553,482 
Asset retirement obligations  (775,248)  —   
Environmental liabilities  (114,068)  —   
Lease liabilities and assets  2   —   
Other operating activities  518   —     —     259 
Net Cash Used in Operating Activities  (3,487,811)  (1,595,607)
Net Cash (Used in) Provided by Operating Activities  (3,975,229)  181,694 
Investing Activities:                
Pre-acquisition costs and deposit on refinery acquisition  —     (1,255,382)  —     (582,634)
Cash paid for acquisition of Alon Bakersfield Property, Inc.  (36,500,000)  —   
Property plant & equipment  (5,487,828  —   
Intangible assets  —     —     (33,766)  —   
Advances to contractors  (19,440,631)  —   
Deposits  —     —   
Property, plant & equipment  (29,844,053)  —   
Net Cash Used in Investing Activities  (61,428,459)  (1,255,382)  (29,877,819)  (582,634)
Financing Activities:                
Proceeds received from exercise of stock options  90,796   —     —     71,596 
Payments on notes payable and long-term debt  (4,746,633)  —     (761,614)  —   
New borrowings  600,560   —   
Long-term debt (credit facility)  80,500,000   —     30,769,958   —   
Payments on debt issuance costs  (4,218,211)  —   
Debt issuance costs  —     (100,000)
Net Cash Provided by Financing Activities  71,625,952   (100,000)  30,608,904   71,596 
                
Net Change in Cash, Cash Equivalents and Restricted Cash  6,709,682   (2,950,989)  (3,244,144)  (329,344)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period  457,331   5,226,489   38,982,725   457,331 
Cash, Cash Equivalents and Restricted Cash at End of Period  7,167,013   2,275,500  $35,738,581  $127,987 
Supplemental Disclosures of Cash Flow Information        
Cash Paid for Interest $3,887,108   —   
Cash Paid for Income Tax  —     —   

 

Supplemental Noncash Investing and Financing Activities

 

During the six monthsquarter ended June 30, 2020, in connection with the Company’s purchase of Alon Properties, Inc., in addition to the cash paid, the Company assumed asset retirement obligations and environmental liabilities of $74.5 million, and issued options with a fair value of $5.5M. The purchase included the acquisition of property and equipment of $116.8 million and intangible assets of $3.4 million.

During the six months ended June 30,March 31, 2020, the Company converted a derivative liability of $19.3 million into a fixed payment obligation with a fair value of $18.8 million, and thereby recognized a gain on derecognition of the derivative liability of $0.5 million.

   

During the six monthsquarter ended June 30, 2020,March 31, 2021, the Company issued warrantsrecognized $1.2 million in debt issuance costs related to a third-party to purchase an equity interest inClass B units of its subsidiary Sustainable Oils, Inc., which warrant had a fair value of approximately $9,000.

that were either issued or became issuable to the lender.

 

During the six monthsquarter ended June 30, 2020,March 31, 2021, the Company financedrecorded debt issuance of $3.8 million in debt issuance costs related to accrued costs due to the creditors of its insurance premiumssenior credit and mezzanine facilities in connection with the fees related to a loan amendment. Approximately $3.1 million of the debt issuance have been allocated to the senior credit facility and $0.7 have been allocated to the mezzanine facility.

During the quarter ended March 31, 2021, the Company issued 1,586,786 shares in connection with the conversion of a note payable and accrued interest of $4.3$0.5 million.

 

During the six monthsquarter ended June 30, 2020,March 31, 2021, the Company converted $0.27capitalized $5.0 million of accrued interest on itsin property, plant and equipment, of which $1.0 million related to in-kind interest that was added to the principal balance of the credit agreementfacility and $0.3 million related to additional principal.

amortization of the debt issuance costs.

 

The accompanying notes are an integral part of these consolidated financial statements

 

 -4-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Description of Business

 

Global Clean Energy Holdings, Inc., a Delaware corporation, and its wholly owned subsidiaries (collectively, the “Company,”“Company”, “we”, “us” or “our”) is a U.S.-based integrated agricultural-energy biofuels company that holds assets across feedstocks and plant genetics, agronomics, cultivation, and regulatory approvals, commercialization, and downstream biorefining and storage. The Company is focused on the development and refining of non-food basednonfood-based bio-feedstocks and has a proprietaryan investment in camelina sativaseveral proprietary varieties of Camelina Sativa (“Camelina”), a fast growing, low input and ultra-low carbonultra-low-carbon intensity crop used as a feedstock for renewable fuels. The Company holds its Camelina assets (including all related intellectual property related rights and approvals) and operates its Camelina business through aits subsidiary, Sustainable Oils Inc., a Delaware corporation.

 

In 2018 and 2019 the Company pursued the acquisition of a crude oil refinery in Bakersfield, California with the objective of retrofitting it to produce renewable diesel from Camelina and other non-food feedstocks. On May 7, 2020 the Company completed the acquisition of the targeted refinery (the “Bakersfield Biorefinery”). The Bakersfield Biorefinery is owned by Bakersfield Renewable Fuel, LLC, (“BKRF”) an indirect subsidiary of Global Clean Energy Holdings, Inc. The retrofitting of the refinery commenced promptly after the acquisition. The engineering and construction of the project is expected to be completed in early 2022 based on our engineering, procurement and construction contract with a substantial completion date of January 22, 2022. After necessary start-up procedures and testing is complete, we expect production to be approximately 10,000 barrels per day (420,000 gallons per day). Although the Bakersfield Biorefinery will have a nameplate capacity of 15,000 barrels per day, we do not expect to produce more than 10,000 barrels per day for at least the first quarteryear of 2022.production. The Company has entered into both a product offtake agreement and a term purchase agreement with a major oil company for the majoritypurchase by the oil company of all, or substantially all, of the renewable diesel to be produced at the Bakersfield Biorefinery.Biorefinery for the first five years of production. See Note B - Basis of Presentation and Liquidity and Note I - Subsequent Events which describes the offtake agreement in more detail.

 

Basis of Presentation

 

The accompanying condensed and consolidated balance sheet of the Company at December 31, 2019, 2020, has been derived from audited condensed and consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed and consolidated financial statements as of June 30, 2020 March 31, 2021 and for the three and six months ended June 30,March 31, 2021 and 2020, and 2019, havehave been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements, and should be read in conjunction with the audited condensed and consolidated financial statements and related notes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 2020 as filed with the U.S. Securities and Exchange Commission (SEC). In the opinion of the Company’s management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to the unaudited condensed and consolidated financial statements. The unaudited condensed and consolidated financial statements include all material adjustments (consisting of all normal accruals) necessary to make the condensed and consolidated financial statements not misleading as required by Regulation S-X Rule 10-01. Operating results for the sixthree months ended June 30, 2020March 31, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 20202021 or any future periods.

 

The accompanying condensed consolidated financial statements include the accounts of Global Clean Energy Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

 -5-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Per Share Information

On March 26, 2021, the Company effected a one-for-ten reverse stock split. All common stock and per share information (other than par value) contained in these financial statements and footnotes have been adjusted to reflect the foregoing reverse stock split. Prior to the reverse stock split the Company had 358,499,606 shares outstanding and immediately after the stock split the Company had 35,850,089 shares outstanding. The Company issued additional shares after the reverse stock split and the outstanding shares as of May 17, 2021 was 38,765,194.

 

Restricted Cash

 

In accordance with the Company’s senior credit agreement (see Note E - Debt), the Company is required to advance the calculated interest expense on its borrowings at the time of such borrowings to the estimated commercial operational date of

 -5-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

the Bakersfield Biorefinery. This interest is deposited into a designated account and the appropriate amount is paid to the lender at the end of each quarter. Additionally, the construction funds are deposited into its own designated account and deposited from that designated account into the Bakersfield Renewable Fuel, LLC account only upon approval by the lenders.lender to pay for specific construction, facility and related costs. These two accounts are restricted and not directly accessible by the Company for general use, although these funds are creditedassets of the Company. The Company estimates how much of this cash is likely to be capitalized into the Company’s balance sheet.Bakersfield Biorefinery project in the form of a long-term asset, and classifies this amount as long-term. The Company makes this determination based on its budget, recent and near-term invoicing, and internal projections.

 

Cash and Cash Equivalents; Concentration of Credit Risk

The Company considers all highly liquid debt instruments maturing in three months or less to be cash equivalents. The Company maintains cash and cash equivalents at high quality financial institutions. However, deposits exceed the federally insured limits. At March 31, 2021, the Company had approximately $34.7 million in uninsured cash.

Property, Plant and Equipment

 

Property, plant and equipment are stated at cost. Depreciation of office equipment is computed using the straight-line method over estimated useful lives of 3 to 5 years. Refinery assets and buildings are depreciated using the straight-line method over estimated useful lives of 105 to 25 years, however,years. However, the refinery will not begin to be depreciated until its retrofitting has been completed and it’sit is ready for operations. Normal maintenance and repair items are charged to operating costs and are expensed as incurred. The cost and accumulated depreciation of property, plant and equipment sold or otherwise retired are removed from the accounts and any gain or loss on disposition is reflected in the statement of operations. Interest on borrowings related to the retrofitting of the Bakersfield Biorefinery is being capitalized, which will continue until the refinery is available for commercial use. During the six monthsquarter ended June 30, 2020, $1.6March 31, 2021, $5.0 million of interest has beenwas capitalized, and is included in property, plant and equipment, net, onfor a total of $15.2 million of capitalized interest for the accompanying June 30, 2020 balance sheet.project.

 

Long-Lived Assets

 

In accordance with U.S. GAAP for the impairment or disposal of long-lived assets, the carrying values of intangible assets and other long-lived assets are reviewed on a regular basis for the existence of facts or circumstances that may suggest impairment. The Company recognizes impairment when the aggregate of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. During the quarters ended March 31, 2021 and March 31, 2020, there were no impairment losses recognized on long-lived assets.

 -6-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Pre-Acquisition Costs

 

We began capitalizing pre-acquisition costs once we determined that the acquisition of the Bakersfield Biorefinery project was probable, which was in April of 2019 when the product offtake agreement was signed. We capitalized those costs directly identifiable with the specific property and those costs that would be capitalized if the property were already acquired. Upon the acquisition of the Bakersfield Biorefinery, these capitalized pre-acquisition costs, which totaled $3.2 million, were reclassified to property and equipment.

  

For the full year of 2019 and for the year 2020 up to and including the acquisition date of May 7, 2020, we capitalized $2.6 million and $0.6 million of these costs, respectively. As of May 7, 2020, we allocated our accumulated pre-acquisition costs of $3.2 million to the acquired Bakersfield Biorefinery. See Note C - Property and Equipment, included herein.

Debt Issuance Costs

 

During 2018, we signed a letter of intent to acquire our Bakersfield Refinery. The acquisition of the refinery and the related $365 million of financing to fund the retrofit closed in May 2020. In connection with financing the refinery, we incurred $0.5approximately $5 million of debt issuance costs as of the date of the closing. However, in 2019 and $4.2 millionconnection with the senior credit facility, we issue the creditors Class B equity units of our subsidiary BKRF OCB, LLC as funds are advanced from the facility. The fair value of these Class B units on the date of issuance is recorded as a liability with an offsetting adjustment to debt issuance costscosts. In addition, in March 2021, we amended our credit agreements (see Note E), and as part of that amendment, we agreed to pay the second quarter of 2020 related to acquisitionlenders a 1% fee in our equity securities based upon the amount of the Bakersfield Biorefinery. facilities, which amounts to $3.8 million.

Debt issuance costs are amortized over the term of the loan as interest: however, as such interest relates to retrofitting of the refinery, these costs are being capitalized as part of the refinery until the refinery is placed in service. The amortization of the debt issuance costs that are not capitalized is recorded as interest expense. At March 31, 2021 and December 31, 2020, unamortized debt issuance costs related to the senior credit facility are classified as a direct deduction from the carrying amount of the credit facility; however, unamortized debt issuance costs related to the mezzanine facility are presented on the balance sheet as an asset as there have not been any borrowings on the mezzanine facility. See Note E - Debt for more detail on the financing.

Accounts Payable and Accrued Liabilities

For presentation purposes, accounts payable and accrued liabilities have been combined. As of March 31, 2021 and December 31, 2020, accounts payable and accrued liabilities consists of:

  As of March 31, 2021 As of December 31, 2020
Accounts payable $12,237,029  $9,724,136 
Accrued compensation and related liabilities  3,163,254   3,034,688 
Accrued interest payable  1,989,423   2,093,649 
Other accrued expenses  7,363,687   3,146,478 
Current portion of asset retirement obligations  4,400,410   3,716,000 
Current portion of environmental liabilities  1,104,106   883,000 
  $30,257,909  $22,597,951 

 -6--7-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

such interest relates to retrofitting of the refinery, these costs will be capitalized as part of the refinery until the refinery is placed in service. The amortization of the debt issuance costs is classified as interest expense unless it meets the criteria to be capitalized. At March 31, 2020 and December 31, 2019, certain unamortized debt issuance costs are presented on the balance sheet as deferred costs. However, upon the closing of the Bakersfield biorefinery acquisition and as of June 30, 2020, these costs are classified as a direct deduction from the carrying amount of the debt liability of the financing to the extent that we borrow on the credit agreements.

Derecognition of Liabilities

The Company reviews its liabilities, including but not limited to, accounts payable, notes payable, accrued expenses, accrued liabilities and other legal obligations for a determination of the legal enforcement or settlement of these obligations. Upon conclusive evidence that an obligation may be extinguished, has expired, is discharged, is cancelled or otherwise no longer legally exists, then the Company will derecognize the respective liability on its balance sheet.

Asset Retirement Obligations

The Company recognizes liabilities which represent the fair value of a legal obligation to perform asset retirement activities, including those that are conditional on a future event, when the amount can be reasonably estimated. If a reasonable estimate cannot be made at the time the liability is incurred, we record the liability when sufficient information is available to estimate the liability’s fair value. We have asset retirement obligations with respect to our Bakersfield Biorefinery due to various legal obligations to clean and/or dispose of these assets at the time they are retired. However, the majority of these assets can be used for extended and indeterminate periods of time provided that they are properly maintained and/or upgraded. It is our practice and intent to continue to maintain these assets and make improvements based on technological advances. In the logistics segment,A portion of these obligations relate to the required cleanout of hydrocarbons previously used in the pipeline and terminal tanks. In order to determine the fair value of the obligations management must make certain estimates and assumptions including, among other things, projected cash flows, a credit-adjusted risk-free rate and an assessment of market conditions that could significantly impact the estimated fair value of the asset retirement obligations. We believe the estimates selected, in each instance, represent our best estimate of future outcomes, but the actual outcomes could differ from the estimates selected.

We estimate our escalation rate at 3.33% and our discount factor ranges from 3.62% in year one to 7.26% in year twenty, with the weighted average discount rate being 5.0%. See Note IH - Commitments and Contingencies for more detail on environmental liabilities, which are accounted for separately from asset retirement obligations.

 

The following table provides a reconciliation of the changes in asset retirement obligations for the quarter ended March 31, 2021 and the year ended December 31, 2020.

  Three months ended March 31, 2021 Year ended December 31, 2020
Asset retirement obligations - beginning of period $21,478,977  $—   
Additions related to acquisition of refinery  —     21,901,977 
Disbursements  (775,249)  (135,000)
Accretion  245,000   652,000 
Revised obligation estimates  —     (940,000)
Asset retirement obligations - end of period $20,948,728  $21,478,977 

The amount shown as of March 31, 2021 and 2020, includes $4.4 million and $3.7 million, respectively, which has been classified as current liabilities and included in accounts payable and accrued liabilities and $16.5 million and $17.8 million, respectively which have been classified as long-term liabilities as of March 31, 2021 and December 31, 2020, respectively.

Advances to Contractors

Upon the acquisition of the Bakersfield Biorefinery, the Company advanced $20.1 million to its primary engineering, procurement and construction contractor. These funds are credited against future invoices in accordance with an agreed schedule.

As of March 31, 2021, the funds advance has been reduced to $16.0 million.

Income Taxes

 

The Company utilizes the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and the carryforward of operating losses and tax credits, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized. Assets and liabilities are

 -7-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions are judged to not meet the “more-likely-than-not” threshold based on the technical merits of the positions. Estimated interest and penalties related to uncertain tax positions are included as a component of general and administrative expense.

 -8-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606 using the following five-step model: (1) identify the contract with the customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue. The Company did not recognize anyrecognized $0.1 million in revenues during the quartersquarter ended June 30, 2020March 31, 2021 and 2019.had no comparable sales in the quarter ended March 31, 2020. The Company is engaged in contracting with farmers to grow camelina grain that will be processed into oil for use in Bakersfield Biorefinery. The Company will recognize revenues upon the sale of its patented camelina seed to the farmers and also for the crushed camelina meal that it plans to sell to third party livestock and poultry operators. Based upon the Company’s Product Offtake Agreement (see Note B)B - Basis of Presentation and Liquidity), the Company expects to recognize revenue from the sale of biofuel beginning in 2022.

 

Research and Development

 

Research and development costs are charged to operating expenses when incurred.

 

Fair Value Measurements and Fair Value of Financial Instruments

 

As of June 30, 2020March 31, 2021 and December 31, 2019,2020, the carrying amounts of the Company’s financial instruments that are not reported at fair value in the accompanying consolidated balance sheets, including cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their fair value due to their short-term nature. The Company’s derivative liability related to its derivative forward contract is reported at fair value.

 

U.S. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the following fair-value hierarchy:

 

Level 1— Quoted prices for identical instruments in active markets;

 

Level 2— Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

 

Level 3— Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

At December 31, 2019, thethe Company had a derivative liability ofof $24.8 million related to a forward contract that also included a call option. The notional amount of the forward contract related to gallons of the commodity, Ultra Low Sulfur Diesel. Under the terms of the contract the Company was obligated to pay the equivalent of the notional amount multiplied by the market price of Ultra Low Sulfur Diesel at the settlement dates; however, the call option of the contract capped the market price of Ultra Low Sulfur Diesel.

 -8-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

In March of 2020 the Company settled the derivative contract by agreeing to a payment of $5.5 million due on April 30, 2020 and six equal payments beginning in October of 2021 totaling $17.6 million. The Company recognized $5.5 million of income from the decrease in fair value on the derivative contract from January 1, 2020 through March 19, 2020, and also recognized a gain of $512,000 on the derecognition of the derivative contract. The derivative forward contract was amended again in April 2020. Under the amendment, the contract was replaced with a fixed payment obligation, whereby the Company agreed to pay the counterparty a total of $24.8 million, which included a payment of $4.5 million that the Company paid in June 2020, and six equal installment payments beginning in 2022 totaling $20.3 million.

 -9-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

  

The fair value of the derivative forward contract is primarily based upon the notional amount and the forward strip market prices of Ultra Low Sulfur Diesel, and is reduced by the fair value of the call option. The forward strip market prices are observable. However, to determine the fair value of the call option, the Company used the Black’s 76 option pricing model. As a result, the contract as a whole is included in the Level 3 of the fair value hierarchy.

 

The Company’s mandatorily redeemable equity instruments of its subsidiary are also measured at fair value on a recurring basis. See Note E - Debt for more information.

The derivative liability discussed herein was extinguishedderecognized in the first quarter of 2020, and the Company had no derivative liabilities in the second quarter ending June 30, 2020. March 31, 2021. The following presents the change in the derivative liability for the three months ended March 31, 2020:

  Three Months Ended
  March 31, 2020
Beginning Balance $24,767,000 
Conversion to note payable  (19,291,000)
Change in fair value recognized in earnings  (5,476,000)
 Ending Balance $—   

The carrying value of the mandatorily redeemable equity instruments of subsidiary as of March 31, 2021:

  Carrying Value Total Fair Value Quoted prices in active markets for identical assets - Level 1 Significant other observable inputs - Level 2 Significant unobservable inputs - Level 3
Liabilities                    
Mandatorily redeemable equity instruments of subsidiary $7,193,000  $7,193,000  $—    $—    $7,193,000 

The following presents changes in the derivative liabilitymandatorily redeemable equity instruments of subsidiary (Class B Units) through June 30,the three months ended March 31, 2021 and the year ended December 31, 2020:

 

 Six Months Ended
 June 30, 2020 June 30, 2019 Three months ended March 31, 2021 Year ended December 31, 2020
Beginning Balance $24,767,000  $11,917,000  $5,123,000  $—   
Conversion to note payable  (19,291,000)  —   
New unit issuances  1,218,769   3,101,344 
Change in fair value recognized in earnings  (5,476,000)  2,619,000   851,231   2,021,656 
Ending Balance $—    $14,536,000  $7,193,000  $5,123,000 

 -10-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

Estimates

 

Management uses estimates and assumptions in preparing financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and reported revenues and expenses. Significant estimates used in preparing these financial statements include a) valuation of common stock, warrants, and stock options, b) those assumed in determining the value of the derivative transactions, c) estimated useful lives of equipment and intangible assets, d)c) the estimated costs to remediate or clean-up the refinery site, and the inflation rate, discountcredit-adjusted risk-free rate and timing of payments to calculate the asset retirement obligations, andd) the estimated costs to remediate or clean-up identified environmental liabilities, e) the estimated future cash flows and e)the various metrics required to establish a reasonable estimate of the value of the Class B Units, and f) the allocation of the acquisition price of the Bakersfield Biorefinery to the various assets acquired. It is at least reasonably possible that the significant estimates used will change within the next year.

 

Income/Loss per Common Share

 

Income/Loss per share amounts are computed by dividing income or loss applicable to the common stockholders of the Company by the weighted-average number of common shares outstanding during each period. Diluted income or loss per

 -9-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

share amounts are computed assuming the issuance of common stock for potentially dilutive common stock equivalents. The number of dilutive warrants and options is computed using the treasury stock method, whereby the dilutive effect is reduced by the number of treasury shares the Company could purchase with the proceeds from exercises of warrants and options.

 

The following table presents: 1) instruments that were dilutive for the three monthsquarter ended June 30, 2019 and the six months ended June 30,March 31, 2020 andwere included in the diluted earnings per share, and 2) instruments that were anti-dilutive for the three monthsquarter ended June 30, 2020 and six months ended June 30, 2019 andMarch 31, 2021 that were excluded from diluted earnings per share as they would have been anti-dilutive::

 

 For the Three Months ended For the Six Months ended
        
 June 30, June 30, June 30, June 30,
 2020 2019 2020 2019
        
 Instruments Instruments Instruments Instruments
 Excluded in Included in Included in Excluded in
 Diluted EPS Diluted EPS Diluted EPS Diluted EPS
                 Three Months Ended March 31, 2021 Three Months Ended March 31, 2020
Convertible notes and accrued interest  101,091,766   95,955,013   101,091,766   95,955,013   8,906,773   10,007,550 
Convertible preferred stock - Series B  11,818,181   11,818,181   11,818,181   11,818,181   1,181,818   1,181,818 
Stock options and warrants  173,282,235   183,896,134   173,201,523   177,534,870 
Compensation-based stock options and warrants  19,220,714   17,705,000 

 

Stock Based Compensation

 

The Company recognizes compensation expenses for stock-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value. However, in the case of awards with accelerated vesting, the amount of compensation expense recognized at any date will be based upon the portion of the award that is vested at that date. The Company estimates the fair value of stock options using a Black-Scholes option pricing model which requires management to make estimates for certain assumptions regarding risk-free interest rate, expected life of options, expected volatility of stock and expected dividend yield of stock. For the quarters ended June 30, 2020 and 2019, charges related to stock-based compensation amounted to approximately $155,000 and $460,000, respectively. For the six months ended June 30, 2020 and 2019, charges related to stock-based compensation amounted to approximately $181,000 and $503,000, respectively. For all quarters in 2019 and 2020, all stock-based compensation is classified in general and administrative expense.

 

Subsequent Events

 

The Company has evaluated subsequent events through the date these condensed consolidated financial statements were available to be issued. See Note JI to these condensed consolidated financial statements for a description of events occurring subsequent to June 30, 2020.March 31, 2021.

 -11-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE B — BASIS OF PRESENTATION AND LIQUIDITY

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. DuringAs shown in the year ended December 31, 2019 and six months ended June 30, 2020,accompanying consolidated financial statements, the Company incurred losses from continuing operations applicable to its common stockholders of $4.9$8.2 million and $3.0 million, respectively,during the quarter ended March 31, 2021, and has an accumulated deficit applicable to its common stockholders of $54$74.5 million at June 30, 2020.

 -10-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE B — BASIS OF PRESENTATION AND LIQUIDITY (CONTINUED)March 31, 2021. At March 31, 2021, the Company had working capital of negative $13.8 million (which includes current restricted cash of $11.9 million) and total stockholders deficit of $36.4 million. The Company is progressing its Bakersfield Biorefinery retooling project and is on track to achieve its initial revenues from the production and sale of renewable diesel in early 2022.

 

On May 4, 2020, a group of lenders agreed to provide a $300 million senior secured term loan facility to BKRF OCB, LLC, one of Global Clean Energy Holdings, Inc.’s subsidiaries, to enable that subsidiary to acquire the equity interests of Bakersfield Renewable Fuels, LLC and to pay the anticipated costs of the retooling of the Bakersfield Biorefinery owned by Bakersfield Renewable Fuels, LLC. Concurrently with the foregoing senior credit facility, a group of mezzanine lenders also agreed to provide a $65 million secured term loan facility to be used to pay the costs of repurposing and starting up the Bakersfield biorefinery. Although the funds provided by the senior and mezzanine lenders may only be used for the Bakersfield Biorefinery and servicing these debt obligations, since the Company shares facilities and personnel, Global Clean Energy Holdings, Inc. will nevertheless, realize a reduction in certain of its operating expenses.and general and administrative expenses as the Company shares certain personnel and related costs. The Company believes that these cost savings, plus the Company’s other financial resources should be sufficient to fund the Company’s operations through the start-up of the Bakersfield Biorefinery. See “Note E - Debt.Debt” and “Note I - Subsequent Events.On October 12,In November 2020, the groupCompany’s senior and mezzanine facilities were increased by a total of lenders agreed to lend up to an additional $15 million for the Bakersfield Biorefinery and a portion to the Company’s upstream Camelina business. See, “Note J - Subsequent Events.”

 

In April of 2019, the Company executed a binding Product Offtake Agreement (the “Offtake Agreement”) with ExxonMobil Oil Corporation (“Purchaser”) pursuant to which Purchaser has committed to purchase a minimum of 852.5 million gallonsbarrels per year of renewable diesel annually from the Bakersfield Biorefinery (with a right to purchase higher volumes as available), and the Company has committed to sell these quantities of renewable diesel to Purchaser. The Purchaser’s obligation to purchase renewable diesel will last for a period of five years following the date that the Bakersfield Biorefinery commences commercial operations. The Purchaser has the option to extend the initial five-year term. Either party may terminate the Offtake Agreement if the Bakersfield Biorefinery does not meet certain production levels by certain milestone dates following the commencement of the Bakersfield Biorefinery’s operations. See “Note I - Subsequent Events.”

 -12-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE C – PROPERTY, PLANT AND EQUIPMENT

 

On May 7, 2020 through its subsidiary BKRF OCB, LLC, the Company purchased all of the outstanding equity interests of Alon Bakersfield Property, Inc. a company that owned a crude oil refinery in Bakersfield, California from Alon Paramount Holdings, Inc. (“Alon Paramount”) for a total consideration of $120.2 million.$89.4 million (excluding acquisition costs). Immediately prior to the purchase, Alon Bakersfield Property Inc. was converted into a limited liability company and renamed as “Bakersfield Renewable Fuels, LLC.” The Company is now retooling the acquired crude oil refinery into a biorefinery. In accordance with ASC Topic 805, Business Combinations, the Company determined that the purchase is an asset purchase and not a business combination based the following a) substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset group, b) that the existing crude oil based (very high carbon) refinery is not able to produce renewable diesel (very low carbon) fuel, c) no refinery in the U.S. has been designed specifically around the plant oil feedstock ofextracted from Camelina seed,seeds, thus the technical aspect is new and unique to the Bakersfield Biorefinery and d) the Company did not acquire an assembled workforce. Thus, the acquired asset group does not have the full inputs or substantive process to produce outputs and does not have any acquired revenue generating contractual arrangements.

 

The total consideration for the purchase of the Bakersfield Biorefinery was $120.2$89.4 million, and consisted of $40 million of cash, an option right ofvalued at $5.5 million granted to the seller, and an assumption of $74.7$43.9 million of liabilities. The liabilities assumed consist of $40.7$21.9 million of Asset Retirement Obligationsasset retirement obligations (ARO) and $34$22 million of other environmental remediation liabilities. These liabilities are the estimated costs of clean-up, remediation and associated costs of the acquired assets in accordance with current regulations. The option right was valued using various inputs, including a volatility of 116%, a risk free rate of 0.14% and a marketability discount of 25%. The total consideration of the purchase was allocated to the asset categories acquired based upon their relative fair value.value, except that the fair value of the ARO were allocated to the specific assets to which they relate. The following summarizes this allocation of the purchase price and also the reclassification of the pre-acquisition costs:

 -11-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE C – PROPERTY AND EQUIPMENT (CONTINUED)

Asset Category Capitalized Costs Based on Acquisition Valuation Allocated Pre-Acquisition Costs Total Capitalized Costs on Acquisition Capitalized Costs Based on Acquisition Valuation Allocated Pre-Acquisition Costs Total Capitalized Costs on Acquisition
Property and Equipment                  
Land $13,506,000   —    $13,506,000  $7,584,961   —    $7,584,961 
Buildings  3,656,600   —     3,656,600   2,053,570   —     2,053,570 
Refinery  99,614,100   3,222,449   102,836,549   77,845,201   3,222,449   81,067,650 
Intangible Assets   3,420,700   —     3,420,700   1,921,082   —     1,921,082 
Total $120,197,400  $3,222,449  $123,419,849  $89,404,814  $3,222,449  $92,627,263 

 

Property and equipment as of June 30, 2020March 31, 2021 and December 31, 20192020 are as follows:

 

 June 30, 2020 December 31, 2019 March 31, 2021 December 31, 2020
Land $13,506,000   —    $7,584,961   7,584,961 
Office Equipment  61,078   61,078   61,078   61,078 
Buildings  3,656,600   —     2,053,570   2,053,570 
Refinery Equipment  102,836,549   —     103,635,160   86,019,130 
Construction in Process  4,946,792   —     41,684,071   33,212,695 
Construction period interest  15,215,073   10,220,766 
Total Cost $125,007,019   61,078  $170,233,913   139,152,200 
Less accumulated depreciation  (88,109)  (61,078)  (205,195)  (179,525)
Property and equipment, net $124,918,910   —    $170,028,718   138,972,675 

 

Depreciation expense for property and equipment was approximately $27,000$25,000 for the quarter and six months ended June 30, 2020.March 31, 2021. There was no depreciation for the quarter and six months ended June 30, 2019.March 31, 2020.

 

NOTE D – INTANGIBLE ASSETS

Intangible assets consist of patent license fees and refinery permits. Through a 2013 acquisition, the Company acquired certain patents, intellectual property and rights related to the development of Camelina as a biofuels feedstock, as a result of which the Company continues to incur costs related to patent license fees and patent applications for Camelina sativa plant improvements. These acquired assets include three patents and the related intellectual property associated with these

 -12--13-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE D - INTANGIBLE ASSETS (CONTINUED)

 

patents.The Company holds certain patents, intellectual property and rights related to the development of Camelina as a biofuels feedstock and continues to incur costs related to patent license fees and patent applications for Camelina sativa plant improvements. These three patents have an expected useful life of approximately 17 years and are carried at cost less any accumulated amortization and any impairment losses. Amortization is calculated using the straight-line method over their remaining patent life. These three purchasedThe termination dates of our earliest patents expirewill begin to occur in 2029. Any future costs associated with the maintenance of these patents and patent and registration costs for any additionalnew patents that are essential to the Company’sour business will be capitalized and amortized over the life of the patent once issued. Upon the Company’s acquisition of the Bakersfield Biorefinery, the Company acquired necessary permits for the operation of the facility. The permit cost of $3.4$1.9 million is amortized on a straight-line basis over 15 years. The intangible assets as of the quarter ended June 30,March 31, 2021 and December 31, 2020 and 2019 is shown in the following table:

 

 June 30, June 30, March 31, December 31,
 2020 2019 2021 2020
Patent license fees  4,189,952   4,187,902 
Patent licenses  4,476,319   4,442,553 
Refinery permits  3,420,700   —     1,921,082   1,921,082 
Less accumulated amortization  (1,842,640)  (1,686,310)  (2,271,919)  (2,182,889)
Intangible Assets, Net  5,768,012   2,501,592   4,125,482   4,180,746 

 

Amortization expense for intangible assets was approximately $95,000$89,000 and $61,000 for the quarters ended June 30,March 31, 2021 and March 31, 2020, and 2019, respectively. The estimated amortization expense for the next five years is expected to be approximately $500,000 annually.

 -14-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE E – DEBT

 

At June 30, 2020,The table below summarizes our notes payable and long-term debt consisted of the following:at March 31, 2021 and at December 31, 2020:

 

 March 31, 2021 December 31, 2020
Notes Payable        
Senior credit facility $185,141,188  $153,405,569 
Fixed payment obligation, net of discount  16,752,528   16,155,138 
Other notes - current  3,436,499   4,198,113 
Other notes - long-term  600,560   —   
  205,930,775   173,758,820 
Less: unamortized debt issuance costs  (10,715,113)  (6,636,344)
Subtotal  195,215,662   167,122,476 
        
Convertible Notes Payable        
Convertible note payable to executive officer $1,000,000   1,000,000   1,000,000 
Other convertible notes payable  697,000   413,500   697,000 
Fixed payment obligation, net of discount of $5,225,715  15,024,285 
Other notes  5,439,128 
Senior credit facility  80,769,090 
Subtotal  1,413,500   1,697,000 
  102,929,503         
Less: unamortized debt issuance costs  (4,723,928)
 $98,205,575 
Total $196,629,161  $168,819,476 

 

Credit Facilities

 

On May 4, 2020, in order to fund the purchase and subsequent retrofitting of the Bakersfield Renewable Fuels, LLC, BKRF OCB, LLC, a subsidiary of the Company, entered into a senior secured credit agreement with a group of lenders (the "Senior Lenders"“Senior Lenders”) pursuant to which the Senior Lenders agreed to provide a $300 million senior secured term loan facility to BKRF OCB and(which was increased to $313.2 million in November 2020) to pay the costs of the retooling the Bakersfield Biorefinery. The senior loan bears interest at the rate of 12.5% per annum, payable quarterly, provided that the borrower may defer up to 2.5% interest to the extent it does not have sufficient cash to pay the interest, with such deferred interest being added to principal. The principal of the senior loans matures in November 2026, provided that BKRF OCB, LLC must offer to prepay the senior loans with any proceeds of such asset dispositions, borrowings other than

 -13-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE E – DEBT (CONTINUED)

permitted borrowings, proceeds from losses, and excess net cash flow. BKRF OCB, LLC may also prepay the senior loan in whole or in part with the payment of a prepayment premium. As additional consideration for the senior loans, the Senior Lenders are issued Class B Units in BKRF HCP, LLC, an indirect parent company of BKRF OCB, LLC, as the Company draws on the facility. As of June 30, 2020, 80.5March 31, 2021, 182.4 million Class B Units have either been issued or are issuable, and the aggregate fair value of such units on the date of their issuances totaled approximately $4.3 million which were recorded as debt issuance totaled $939,000.costs. The aggregate fair value of the earned units as of March 31, 2021 was approximately $7.2 million. The fair value of such units is remeasured at each new issuance and at each quarter end. It is expected that the fair value will increase as the Company continues to de-risk the project through ongoing retooling activities. The senior loans are secured by all of the assets of BKRF OCB, LLC (including its membership interests in Bakersfield Renewable Fuels, LLC), all of the outstanding membership interest in BKRF OCB, LLC, and all of the assets of Bakersfield Renewable Fuels, LLC. The credit facility contains certain covenants. In March 2021, the Company and the lenders amended the credit agreements, thereby bringing the Company into compliance with the covenants and as of June 30, 2020,the amendment date.

 -15-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE E – DEBT (CONTINUED)

Effective March 26, 2021, the Company was in compliance with alland its Senior Lenders entered into Amendment No. 3 to the Credit Agreement to, among other things, establish a contingency reserve account to fund the costs of the covenants.additional capabilities and equipment and to fund possible cost overruns at the Bakersfield Biorefinery. Concurrently, the Company and the mezzanine lenders entered into Consent No. 2 And Amendment No. 2 To Credit Agreement to amend the $65 million mezzanine credit facility. Under these two amendments we agreed to establish an additional cash reserve of at least $35 million, which cash reserve would be used at the direction of the agent for the lenders to fund project costs of the Bakersfield Biorefinery to the extent that such costs exceed the amounts available under the two credit agreements. Funds remaining in the additional reserve account after the completion of the Bakersfield Biorefinery will, with the approval of the lenders’ agent, be used to first make a $5 million principal payment on the senior loan, and any remaining funds will be returned to us. In order to fund the new $35 million contingency cash reserve, the two amendments to the credit agreements provide that we will raise no less than $35 million in a public or private financing transaction by July 31, 2021 and that we will deposit, by that date, at least $35 million into the new Bakersfield Biorefinery cash reserve account. As consideration for the amendments to the two credit agreements, we agreed to pay each senior and mezzanine lender an amendment and consent premium equal to 1.00% of the aggregate commitments and loans of such lender. The fee is payable in the same securities that we may issue in connection with raising the $35 million cash reserve. If we fund the $35 million cash reserve other than through a financing transaction, we will pay the 1% lenders’ premium in shares of our common stock or in cash.

 

On May 4, 2020, BKRF HCB, LLC, the indirect parent of BKRF OCB, LLC, entered into a credit agreement with a group of mezzanine lenders who agreed to provide a $65 million secured term loan facility to be used to pay the costs of repurposing and starting up the Bakersfield biorefinery. As of November 30, 2020,March 31, 2021, BKRF HCB, LLC has not drawn down on the credit facility. The mezzanine loans bear interest at the rate of 15.0% per annum on amounts borrowed, payable quarterly, provided that the borrower may defer up to 2.5% interest to the extent it does not have sufficient cash to pay the interest, suchinterest. Such deferred interest beingis added to principal. As additional consideration for the mezzanine loans, the mezzanine lenders will be issued Class C Units in BKRF HCP, LLC at such times as advances are made under the mezzanine loans. The mezzanine loans will be secured by all of the assets of BKRF HCP, LLC, including all of the outstanding membership interest in BKRF HCB, LLC. The mezzanine loans mature in November 2027.

Promissory Notes

Prior to 2016 the Company invested in and purchased various assets and is carrying a note, that is due upon demand, related to such assets in the principal amount of $1.3 million. The promissory note is due upon demand, and has an interest rate of 18% per annum.

Convertible Note Payable to Executive Officer

On October 16, 2018, Richard Palmer, the Company’s Chief Executive Officer and President, entered into a new employment agreement with the Company and concurrently agreed to defer $1 million of his accrued unpaid salary and bonus for two years. In order to evidence the foregoing deferral, the Company and Mr. Palmer entered into a $1 million convertible promissory note (the “Convertible Note”). The Convertible Note is accruing simple interest on the outstanding principal balance of the note at the annual rate of five percent (5%) and became due and payable on October 15, 2020, its maturity date. Under its existing credit agreements, the Company is restricted from repaying Mr. Palmer’s loan and, accordingly, is currently in default under the Convertible Note. As of the quarters ended June 30, 2020 and 2019 the Company had recorded accrued interest payable of approximately $85,000 and $35,000 respectively. Under the Convertible Note, Mr. Palmer has the right, exercisable at any time until the Convertible Note is fully paid, to convert all or any portion of the outstanding principal balance and accrued and unpaid interest into shares of the Company’s Common Stock at an exercise price of $0.0154 per share.

Convertible Notes Payable

The Company has several notes that are convertible into the Company or the Company’s subsidiaries shares at different prices: ranging from $0.03 per share into the parent company’s stock and up to $1.48 per share into a subsidiary’s common stock. These notes have passed their original maturity date and they continue to accrue interest at varying rates, from 8% to

 -14-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE E – DEBT (CONTINUED)

10%. On a combined basis, as of June 30, 2020 the principal amount of these notes is approximately $0.7 million.

 

Fixed Payment Obligation

 

As described in Note A, under “Fair Value Measurements and Fair Value of Financial Instruments”, the Company amended a derivative forward contract during the quarter ended March 31, 2020, with the counterparty. The amendment terminated the derivative forward contract and replaced it with a fixed payment obligation. Under the terms of the fixed payment obligation, the Company agreed to pay the counterparty a total of $23.1 million, which included a payment of $5.5 million in April 2020, and six equal installment payments in 2022 totaling $17.6 million. Under the subsequent revised terms of the fixed payment obligation in April 2020, the Company agreed to pay the counterparty a total of $24.8 million, which included a payment of $4.5 million in June 2020 (which was paid), and six equal monthly equal installment payments beginning in April,May 2022. For financial reporting purposes, the fixed payment obligation has been recorded at the present value of future payments, or $16.8 million, using a discount rate of 14.8%.

 

Insurance Premium FinancingOther Notes Payable

Included in “other notes” as of March 31, 2021, in the above table, is a note, that is due upon demand related to the Company’s business activities prior to 2019, in the principal amount of $1.3 million and an interest rate of 18% per annum. Also, included in other notes above, is a note payable that was used to finance the Company’s insurance policies. Upon the acquisition of the Bakersfield Biorefinery in May 2020, the Company boundpurchased numerous insurance contracts to cover its corporate, ownership and construction risks primarily to provide financial protection against various risks and to satisfy certain lender requirements. The Company paid 35% of the total premiums and financed the balance at 3.8% annual interest rate. The Company is obligated to make seventeen equal monthly payments totaling approximately $4.5 million beginning in July 2020. The insurance policies cover various periods from 12 to 60 months. As of March 31, 2021, the Company had eight payments remaining for a total of $2.1 million.

 -16-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE FEMANDATORILY REDEEMABLE PREFERRED EQUITYDEBT (CONTINUED)

Convertible Note Payable to Executive Officer

On October 16, 2018, Richard Palmer, the Company’s Chief Executive Officer and President, entered into a new employment agreement with the Company and concurrently agreed to defer $1 million of his accrued unpaid salary and bonus for two years. In order to evidence the deferral, the Company and Mr. Palmer entered into a $1 million convertible promissory note (the “Convertible Note”). The Convertible Note accrues simple interest on the outstanding principal balance of the note at the annual rate of five percent (5%) and became due and payable on October 15, 2020, its maturity date. Under its existing credit agreements, the Company is restricted from repaying Mr. Palmer’s loan and, accordingly, is currently in default under the Convertible Note. The Company accrued interest expense of $12,500 on this note in each quarter ended March 31, 2021 and 2020. As of the quarters ended March 31, 2021 and 2020, the Company had recorded accrued interest payable of approximately $122,000 and $72,000 respectively. Under the Convertible Note, Mr. Palmer has the right, exercisable at any time until the Convertible Note is fully paid, to convert all or any portion of the outstanding principal balance and accrued and unpaid interest into shares of the Company’s Common Stock at an exercise price of $0.154 per share.

Convertible Notes Payable

The Company has several notes that are convertible into shares of the Company or the Company’s subsidiaries at different prices: ranging from $0.30 per share into the parent company’s stock and up to $1.48 per share into a subsidiary’s common stock. These notes have passed their original maturity date and they continue to accrue interest at varying rates, from 8% to 10%. On March 26, 2021, we issued 1,586,786 shares of the Company’s common stock to the holder of a convertible promissory note upon the conversion of the entire outstanding balance, principal and accrued interest, for that note. On a combined basis, as of March 31, 2021 the principal amount of these remaining outstanding notes was approximately $0.4 million.

The following table summarizes the minimum required payments of notes payable and long-term debt as of March 31, 2021:

Year Required Minimum Payments
 2021  $3,849,999 
 2022   21,250,000 
 2023   —   
 2024   —   
 2025   —   
 Thereafter   185,741,748 
       
 Total  $210,841,747 

Class B Units of Subsidiary Issued to Lenders

 

As described above, during the quarteryear ended June 30,December 31, 2020 and through March 31, 2021, the Company issued its lenders on its senior debt 80.5or had issuable 184.2 million Class B Units of its subsidiary, BKRF HCB, LLC. TheLLC, to its Senior Lenders. To the extent that there is distributable cash, the Company is obligated to make certain distribution payments to holders of these preferred units,Class B Units, and after the distributions reach a certain limit the units arewill no longer require further distributions and will be considered fully redeemed. The Class B unit holders may receive a portion of the distributable cash, as defined under the Credit Agreement, available to BKRF HCB, LLC, but generally only up to 25% of the available cash after the required interest and principal payments, operating expenses and ongoing capital requirements have been paid. Such payments may commence once the Bakersfield Biorefinery begins operations and will continue through the later of five years after operations of the refinery begins or until the cumulative distributions reach a certain threshold defined in the operating agreement of BKRF HCB, LLC. The Company has estimated the aggregate amount of distributions to the Class B Unit holders (upon the total amount under the credit facility to be drawn) may range from $13 million to as much as $171 million, provided that the aggregate total payments (including distributions to the Class B Units, all interest and principal payments) to the Senior Lenders cannot exceed two times the amount of the borrowings under the Credit Agreement, or approximately $626 million. As such,of March 31, 2021, the Company has valued the liability based on the estimated fair value for the Class B Unit distributions at approximately $7.2 million. The fair value is largely based on the present value of the expected distributions that will be made to the Class B Unit holders, which consider various risk factors, including a market risk premium, project size, the uniqueness and age of the refinery, the volatility of the feedstock and refinery inputs, operational costs, environmental costs and compliance, effective tax rates, illiquidity of the units, etc. As completion of retrofitting the refinery progresses, the fair value is expected to increase, and further increases in fair value are expected when the refinery becomes operational and begins generating revenues. For accounting purposes, these preferred unitsClass B Units are considered to be mandatorily redeemable and have been classified as liabilities in the accompanying June 30, 2020,March 31, 2021 balance sheet.sheet and are remeasured at fair value at the end of each reporting period.

 -17-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE G –F - STOCKHOLDERS’ EQUITY

 

Common Stock

 

In the secondfirst quarter of 2020,2021, the Company issued a total of 6,292,857did not issue any shares of common stock related toits Common Stock upon the exercise of stock options. These option exercises consisted

On March 26, 2021, we issued 1,586,786 shares of 5,542,857the Company’s common stock to the holder of a convertible promissory note upon the conversion of the entire outstanding balance, principal and 750,000 shares issued to an officer and a consultant, respectively.accrued interest, for that note which was $476,036.

 

Series B Preferred Stock

 

On November 6, 2007, the Company sold a total of 13,000 shares of Series B Convertible Preferred Stock (“Series B Shares”) to two investors for an aggregate purchase price of $1.3 million, less offering costs of $9,265. Each share of the Series B Shares has a stated value of $100.


 -15-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE G – STOCKHOLDERS’ EQUITY (CONTINUED)

 

The Series B Shares may, at the option of each holder, be converted at any time or from time to time into shares of the Company’s Common Stock at the conversion price then in effect. The number of shares into which one Series B Share shall be convertible is determined by dividing $100 per share by the conversion price then in effect. The initialcurrent conversion price per share for the Series B Shares is $0.11,$1.10, which is subject to adjustment for certain events, including stock splits, stock dividends, combinations, or other recapitalizations affecting the Series B Shares.

 

Each holder of Series B Shares is entitled to the number of votes equal to the number of shares of the Company’s Common Stock into which the Series B Shares could be converted on the record date for such vote, and has voting rights and powers equal to the voting rights and powers of the holders of the Company’s Common Stock.

 

No dividends are required to be paid to holders of the Series B shares. However, the Company may not declare, pay or set aside any dividends on shares of any class or series of the Company’s capital stock (other than dividends on shares of our Common Stock payable in shares of Common Stock) unless the holders of the Series B shares shall first receive, or simultaneously receive, an equal dividend on each outstanding share of Series B shares.

 

In the event of any liquidation, dissolution or winding up of the Company, the holders of the Series B Preferred Stock shall be entitled to receive, prior to any distribution to the holders of the Common Stock, an amount equal to $100 per share, or $1,300,000$1.3 million in the aggregate, plus an amount equal to any dividends declared and unpaid with respect to each such share.

 

NOTE H – STOCK OPTIONS AND WARRANTS

2010 Equity Incentive Plan

In 2010, the Company’s Board of Directors adopted the Global Clean Energy Holdings, Inc. 2010 Equity Incentive Plan (the “2010 Plan”) wherein 20,000,000 shares of the Company's common stock were reserved for issuance thereunder. As of March 31, 2019, there were no shares available for future option grants under the 2010 Plan. The 2010 Plan expired in April 2020 and was replaced with the 2020 Equity Incentive Plan. There were no grants of stock options in the first quarter of 2020.

2020 Equity incentive Plan

On April 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (“2020 Plan”) pursuant to which the Board of Directors reserved an aggregate of 20,000,000 shares of Common Stock for future issuance. The 2020 Plan became effective on April 10, 2020. As of November 30, 2020, options for the purchase of 7,170,000 shares have been granted under the 2020 Plan to attract and retain the necessary personnel to meet the Company’s objectives. The 2020 Plan will expire on April 9, 2030, and no further awards may be granted after such date. The 2020 Plan provides for the following types of awards: incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards. Stock awards may be granted under the 2020 Plan to employees (including officers) and consultants of the Company or affiliates, and to members of the Company’s Board of Directors.

During the second quarter ended June 30, 2020 the Company granted stock options for the purchase of a total of 15,030,000 shares of Common Stock under the 2020 Plan, of which 6,655,000 were to employees and 8,375,000 were non-qualified stock options to non-employees.

 -16--18-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE HG – STOCK OPTIONS AND WARRANTS (CONTINUED)

2020 Equity incentive Plan

In April 2020, the Company’s Board of Directors adopted the Global Clean Energy Holdings, Inc. 2020 Equity Incentive Plan (the “2020 Plan”) wherein 2,000,000 shares of the Company’s common stock were reserved for issuance thereunder. Options and awards granted to new or existing officers, directors, employees, and non-employees vest ratably over a period as individually approved by the Board of Directors generally over three years, but not in all cases. The 2020 Plan provides for a three-month exercise period of vested options upon termination of service. The exercise price of options granted under the 2020 Plan is equal to the fair market value of the Company’s common stock on the date of grant. Options issued under the 2020 Plan have a maximum term of ten years for exercise and may be exercised with cash consideration or through a cashless exercise in which the holder forfeits a portion of the award in exchange for shares of common stock of the remaining portion of the award. As of March 31, 2021, there were 825,000 shares available for future option grants under the 2020 Plan.

 

During the six monthsfirst quarter ended June 30, 2020,March 31, 2021 the Company issued 5,542,857granted stock options for the purchase of a total of 140,500 shares 7,677,315 shares, 500,000 sharesof Common Stock under the 2020 Plan, of which 100,500 were to employees and 750,000 shares upon exercises of outstanding options40,000 were to an officer, consultant and director of the Company, and an attorney who provided services to the Company, respectively.directors.

A summary of the option award activity in 20202021 and awards outstanding at June 30, 2020March 31, 2021 is as follows:

 

      Weighted  
    Weighted Average  
  Shares Average Remaining Aggregate
  Under Exercise Contractual Intrinsic
  Option Price Life (Years) Value
         
Outstanding at December 31, 2019  199,027,315   0.016   3.6  $14,360,463 
                 
Granted  15,030,000   0.073       —   
Exercised  (14,470,172)  0.006       —   
Forfeited  (5,000,000)  0.090       —   
Expired  (1,800,000)  0.01       —   
                 
Outstanding at June 30, 2020  192,787,143   0.021   3.5  $13,602,106 
                 
Vested and exercisable at June 30, 2020  175,765,145   0.018   3.4  $12,897,568 

      Weighted  
    Weighted Average  
  Shares Average Remaining Aggregate
  Under Exercise Contractual Intrinsic
  Option Price Life (Years) Value
         
Outstanding at December 31, 2020  19,230,214   0.16   3.9  $30,044,649 
                 
Granted  140,500   5.92         
Exercised  —     —           
Forfeited  (100,000)  0.41       —   
Expired  —     —         —   
                 
Outstanding at March 31, 2021  19,270,714   2.56   2.8  $116,514,943 
                 
Vested and exercisable at March 31, 2021  18,123,095   1.97   2.7  $110,605,999 

 -19-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE G – STOCK OPTIONS AND WARRANTS (CONTINUED)

 

The fair value of stock option grants with only continued service conditions for vesting is estimated on the grant date using a Black-Scholes option pricing model. The following table illustrates the assumptions used in estimating the fair value of options granted during the periods presented:

 

 -17-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE H – STOCK OPTIONS AND WARRANTS (CONTINUED)

 Quarter ended June 30, 2020 Six months ended June 30, 2020 Three months ended March 31, 2021
Expected Term (in Years)  2 to 5   2 to 5   2 to 5 
Volatility  85%  85%  85%
Risk Free Rate  1.4%  1.4%  1.4%
Dividend Yield  0%  0%  0%
Suboptimal Exercise Factor (1)  1.3   1.3   1.3 
Exit Rate Pre-vesting (2)  0%  0%  0%
Exit Rate Post-vesting (3)  0%  0%  0%
Aggregate Grant Date Fair Value $499,935  $499,935  $470,630 

 

(1)The suboptimal exercise factor estimates the value realized by the holder upon exercise of the option and the estimated point at which an option holder would exercise an in-the-money option. The Company estimated the suboptimal factor based on the holder realizing a pre-tax profit of $500,000. Used for lattice model purposes only.

(2)Assumed forfeiture rate for market condition option awards prior to vesting. Used for lattice model purposes only.

(3)Assumed expiration or forfeiture rate for market condition option awards after vesting. Used for lattice model purposes only.

 

For the quarters ended June 30,March 31, 2021 and 2020, and 2019 Thethe Company recognized stock compensation expenses related to stock option awards for the quarters ended June 30, 2020of $102,000 and 2019 of $155,186 and $460,395 respectively, and for the six months ended June 30, 2020 and June 30, 2019 of $180,800 and $503,403,$25,614 respectively. The Company recognizes all stock-based compensation in general and administrative expenses in the accompanying condensed consolidated statements of operations. As of June 30, 2020,March 31, 2021, there was approximately $410,000$448,000 of unrecognized compensation cost related to option awards that will be recognized over the remaining service period of approximately 3.43.3 years.

 

Stock Purchase Warrants and Call Option

In the quarter ended March 31, 2021, the Company did not issue any new warrants to purchase shares of Global Clean Energy Holdings, Inc.

 

In 2020, the Company issued, to a party interested in Camelina development, a non-transferable warrant for the purchase of an approximately eight-percent interest in its subsidiary, Sustainable Oils, Inc. for approximately $20 million. The warrant expires on June 1, 2021. The Company determinedAt the time of issuance, the fair value of the warrantswarrant was deemed to be approximately $9,000.immaterial.

 

Concurrently with the closingacquisition of the acquisition of Bakersfield Renewable Fuels, LLC in May 2020, the Company entered into a Call Option Agreement withBiorefinery, GCEH, through its subsidiary, GCE Acquisitions, issued an option right to the seller Alon Paramount, pursuantof the refinery to which the Company granted to Alon Paramount an option to purchase from Global Clean Energy Holdings, Inc. up to 33 1/3% of the membership interests of a subsidiary that indirectly owns Bakersfield Renewable Fuels, LLC.GCE Acquisitions. The fair value of the option exercise price is basedright on the cash purchase price that the Company paid for Bakersfield Renewable Fuels, LLC. The foregoing option can be exercised by Alon Paramount until the 90th daydate of issuance was $5.5 million and expires at ninety days after the refinery meets certain operational criteria. Upon the exercise of the option, Alon Paramount will be allocated its share of the refinery’s assets and liabilities and profits and losses. Bakersfield Renewable Fuels, LLC is also responsible for all

 -18--20-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE H – STOCK OPTIONS AND WARRANTS (CONTINUED)

of the environmental liabilities and clean up costs associated with the Bakersfield Refinery.

NOTE I – COMMITMENTS AND CONTINGENCIES

 

Employment Agreements

 

The Company maintains an employment agreement with its Chief Executive Officer, and Executive Vice-President and Chief Financial Officer that provide for the terms of their compensation, including bonuses and share-based compensation. See the Company’s December 31, 20192020 Form 10-K (as amended) for further details.

 

Engineering, Procurement and Construction Contract

 

On April 30, 2020, GCE Acquisitions entered into an Engineering, Procurement and Construction Agreement with ARB, Inc. (“ARB”)a national engineering firm pursuant to which ARB hasthis firm agreed to provide services for the engineering, procurement, construction, start-up and testing of the Bakersfield Biorefinery. The agreement, which was assigned by GCE Acquisitions to BKRF OCB, LLC, the borrower under the senior credit facility, provides for ARBthis engineering firm to be paid on a cost pluscost-plus fee basis subject to a guaranteed maximum price of $201.4 million, subject to increase for approved change orders. As of May 17, 2021, the remaining balance of the contract was approximately $151 million.

Environmental Remediation Liabilities

The Company recognizes its asset retirement obligation and environmental remediation liabilities in accordance with ASC 410-30, and has estimated such liabilities as of its acquisition date. It is the Company’s policy to accrue environmental and clean-up related costs of a non-capital nature when it is both probable that a liability has been incurred and the amount can be reasonably estimated. Environmental remediation liabilities represent the current estimated costs to investigate and remediate contamination at our properties. This estimate is based on internal and third-party assessments of the extent of the contamination, the selected remediation technology and review of applicable environmental regulations, typically considering estimated activities and costs for 1520 years, and up to 30 years if a longer period is believed reasonably necessary. Accruals for estimated costs from environmental remediation obligations generally are recognized no later than completion of the remedial feasibility study and include, but are not limited to, costs to perform remedial actions and costs of machinery and equipment that are dedicated to the remedial actions and that do not have an alternative use. Such accruals are adjusted as further information develops or circumstances change. We discount environmental remediation liabilities to their present value if payments are fixed and determinable. However, as the timing and amount of these costs were undeterminable as of March 31, 2021, these costs have not been discounted. Expenditures for equipment necessary for environmental issues relating to ongoing operations are capitalized. Changes in laws and regulations and actual remediation expenses compared to historical experience could significantly impact our results of operations and financial position. We believe the estimates selected, in each instance, represent our best estimate of future outcomes, but the actual outcomes could differ from the estimates selected. At March 31, 2021, accrued environmental remediation liability costs totaled $21.2 million of which $1.1 million have been classified as current liabilities.

Legal

 

On May 7, 2020 through BKRF OCB, LLC, one of the Company’s indirect subsidiaries, the Company purchased all of the outstanding equity interests of Bakersfield Renewable Fuels, LLC from Alon Paramount Holdings, Inc. (“Alon Paramount”) for a total consideration of $89.4 million, including $40 million in cash.cash and assumption of liabilities of $43.9 million. Bakersfield Renewable Fuels, LLC owns an oil refinery in Bakersfield, California that the Company is retooling into a biorefinery. In connection with the acquisition, BKRF OCB, LLC agreed to undertake certain cleanup activities

 -19-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE H – STOCK OPTIONS AND WARRANTS (CONTINUED)

at the refinery and provide a guarantee for liabilities arising from the cleanup. The Company has assumed significant environmental and clean-up liabilities associated with the purchase of the Bakersfield Refinery.

 -21-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE H – COMMITMENTS AND CONTINGENCIES (CONTINUED)

 

Bakersfield Renewable Fuels, LLC, formerly Alon Bakersfield Property, Inc., is one of the parties to an action pending in the United States Court of Appeals for the Ninth Circuit. In June 2019, the jury awarded the plaintiffs approximately $6.7 million against Alon Bakersfield Property, Inc. and Paramount Petroleum Corporation (a parent company of Alon Bakersfield Property, Inc. at the time of the award in 2019). Under the Share Purchase Agreement,agreements pursuant to which we purchased Bakersfield Renewable Fuels, LLC (Alon Bakersfield Property, Inc.) Alon Paramount agreed to assume and be liable for (and to indemnify, defend, and save Bakersfield Renewable Fuels harmless from) this litigation. In addition, Paramount Petroleum has posted a bond to cover this judgment amount. All legal fees in this matter are being paid by Alon Paramount. As Paramount Petroleum Corporation and the Company are jointly and severally liable for the judgement, and Paramount Petroleum Corporation has agreed to absorb all of the liability and has posted a bond to cover the judgement amount, no loss has been accrued by the Company with respect to this matter.

 

In August 2020, a complaint was filed against GCE Holdings Acquisitions, LLC for a claimed breach of a certain consulting agreement. The claim is for $1.2 million. On October 14, 2020, GCE Holdings Acquisitions, LLC filed an answer and denied all allegations in the complaint. The Company does not believe that the ultimate resolution of this matter will have a material effect on its financial statements, and no loss has been accrued regarding this claim.

 

In the ordinary course of business, the Company may face various claims brought by third parties and the Company may, from time to time, make claims or take legal actions to assert the Company’s rights, including intellectual property rights, contractual disputes and other commercial disputes. Any of these claims could subject the Company to litigation. Management believes the outcomes of currently pending claims will not likely have a material effect on the Company’s consolidated financial position and results of operations.

 

Indemnities and Guarantees

 

In addition to the indemnification provisions contained in the Company'sCompany’s organization documents, the Company generally enters into separate indemnification agreements with the Company'sCompany’s directors and officers. These agreements require the Company, among other things, to indemnify the director or officer against specified expenses and liabilities, such as attorneys'attorneys’ fees, judgments, fines and settlements, paid by the individual in connection with any action, suit or proceeding arising out of the individual'sindividual’s status or service as the Company'sCompany’s directors or officers, other than liabilities arising from willful misconduct or conduct that is knowingly fraudulent or deliberately dishonest, and to advance expenses incurred by the individual in connection with any proceeding against the individual with respect to which the individual may be entitled to indemnification by the Company. The Company also indemnifies its lessor in connection with its facility lease for certain claims arising from the use of the facility. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated nor incurred any payments for these obligations and, therefore, no liabilities have been recorded for these indemnities and guarantees in the accompanying condensed consolidated balance sheets.

 

COVID-19

 

In December 2019, a novel strain of coronavirus diseases (“COVID-19”) was first reported in Wuhan, China. Less than four months later, on March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. The extent of COVID-19’s effect on the Company’s operational and financial performance will depend on future developments, includingis ongoing but the duration, spread and intensity ofCompany believes that the pandemic allto date has not materially impacted the Company’s operations and that the pandemic is not expected to be materially disruptive to its future plans and targeted date of which are uncertain and difficult to predict considering the rapidly evolving landscape.beginning commercial operations. The Company is currently analyzinghas implemented strict protocols on its on-site workforce and continues to monitor the potential impacts to its business. At this time, it isThe Company expects that the future impacts due to COVID-19 are not possiblelikely to determine the magnitude of the overall impact of COVID-19 on the Company.be disruptive to its ongoing business.

 

 -20--22-

GLOBAL CLEAN ENERGY HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE JI – SUBSEQUENT EVENTS

 

On October 12, 2020 the Company’s senior and mezzanine lenders agreed to make an additional $15 million available toApril 13, 2021, the Company if requested, to developraised $3.1 million in a private placement by selling 496,000 shares at $6.25 per share and issuing warrants for the Bakersfield Refinerypurchase of 19,840 shares. The warrants have an exercise price of $6.25 per share and a five-year term and are fully vested. If the feedstock program.warrants are exercised, the Company will receive additional proceeds of $124,000.

On October 12, 2020April 15, 2021, the Company acquired 100% of the outstanding equity of Agribody Technologies, Inc., a private agricultural biotechnology company, in an all-stock transaction for a total value of approximately $5 million. In consideration for the shares of Agribody Technologies, Inc. the Company issued 830,526 shares at an approximate value of $6.02 per share.

On April 20, 2021, our BKRF subsidiary entered into a $1.5Term Purchase Agreement (“TPA”) with ExxonMobil Oil Corporation (“ExxonMobil”) under which ExxonMobil has the right to purchase additional quantities of renewable diesel from our Bakersfield Biorefinery, and we are obligated to sell such additional amounts of renewable diesel to ExxonMobil. Under the Offtake Agreement, signed in 2019, ExxonMobil committed to purchase 2.5 million contractbarrels of renewable diesel per year (the “Committed Volume”) from the Bakersfield Biorefinery. However, the Bakersfield Biorefinery is designed to produce more than the Committed Volume. Under the TPA, ExxonMobil has the exclusive right to purchase all renewable diesel produced in excess of the Committed Volume that we sell to ExxonMobil under the Offtake Agreement. We have also agreed to transfer title to ExxonMobil of the RINs allocated to the quantities of renewable diesel purchased under the TPA. In the event that ExxonMobil does not purchase all of the renewable diesel that it can under the TPA and, as a result our inventory levels exceed certain specified levels, we can sell that extra inventory to third parties. ExxonMobil will pay us a price for the renewable diesel purchased under the TPA based on a tiered formula reflecting the margins realized by ExxonMobil from its downstream resales of the TPA renewable diesel. The TPA has a five-year term. ExxonMobil has the option to extend the initial five-year term for a second five-year term if it elects to extend the Offtake Agreement.

On May 12, 2021, the Company repaid in full an outstanding convertible note for a cash payment of $487,000 (including both principal and interest). The Company no longer has any convertible notes into GCEH shares outstanding.

On May 18, 2021 our BKRF subsidiary and CTCI Americas, Inc., a Texas corporation (“CTCI”), entered into a Turnkey Agreement with a Mid-West seed company to manage up to 500 acres of Camelina seed productionGuaranteed Maximum Price for the specific purposeEngineering, Procurement and Construction of harvesting, transporting, cleaningthe Bakersfield Renewable Fuels Project (the “CTCI EPC Agreement”). CTCI Americas is a worldwide leading provider of reliable engineering, procurement and packagingconstruction services, including for the finished Camelina seed, which isrefinery market. Under the CTCI EPC Agreement, CTCI has agreed to provide services to complete the engineering, procurement, construction, pre-commissioning, commissioning, start-up and testing of our renewable diesel production facility under construction in Bakersfield, California. The CTCI EPC Agreement requires the Bakersfield Biorefinery to be certified assubstantially complete, and to be ready for commercial operations, on January 22, 2022. CTCI’s fees and costs, including direct costs, overhead fees and the Company’s proprietary seedcontractor’s fee, are guaranteed not to exceed $178 million (which maximum price is subject to adjustment for certain change orders). The obligations of CTCI have been guaranteed by CTCI Corporation, the Taiwanese parent company of CTCI.

On May 18, 2021 certain of our subsidiaries, including Bakersfield Renewable Fuels, LLC, entered into Amendment No. 4 to our Credit Agreement with the Senior Lenders. The Amendment was entered into primarily to consent to the Company’s standards. This seed will be grown inreplacement of the ARB EPC Agreement with the CTCI EPC Agreement.

On May 19, 2021 we notified ARB, Inc. that we were terminating that certain Engineering, Procurement and Construction Agreement dated April 30, 2020 with ARB, Inc. (the “ARB EPC Agreement”), effective immediately. The subcontracts for the purpose of providingBakersfield Biorefinery will remain in effect and are being subsumed in the seedCTCI EPC Agreement. Accordingly, the subcontractors will continue to growersprovide their services for the 2022 growing season. The contract anticipates a total yield of certified seed of approximately 900,000 lbs. or enough seed to plant approximately 110,000 acres.

On November 17, 2020, the Company held its annual meeting of stockholders at which i) the 2020 Equity Incentive Plan and ii) the proposal to effect a reverse stock split of the common shares at a ratio of 1-for-10, at the discretion of the Board, were approved. The Board, while considering market conditions, anticipates completing the reverse split of the common shares in early 2021.Bakersfield Biorefinery through CTCI.

 -21--23-

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

This report contains forward-looking statements. These statements relate to future events or the Company’s future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “except,“expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Company, nor any other person, assumes responsibility for the accuracy and completeness of the forward-looking statements. The Company is under no obligation to update any of the forward-looking statements after the filing of this Quarterly Report on Form 10-Q to conform such statements to actual results or to changes in its expectations.

 

The following discussion should be read in conjunction with the Company’s unaudited condensed consolidated financial statements and the related notes and other financial information appearing elsewhere in this Form 10-Q. Readers are also urged to carefully review and consider the various disclosures made by the Company which attempt to advise interested parties of the factors which affect the Company’s business, including without limitation the disclosures made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” under the caption “Risk Factors,” and the audited consolidated financial statements and related notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 20192020 and other reports and filings made with the Securities and Exchange Commission (“SEC”).

 

Overview

Since 2007,2013 Global Clean Energy Holdings, Inc. and its subsidiaries (collectively, hereafterhereinafter the “Company”, “we”, “us”“Company,” “we,” “us,” or “our”)“our) has been an integrated agricultural-energyengaged in developing its Camelina assets as a biofuels company that, directly or through its subsidiaries, acquired and developed agricultural biofuel feedstock assets. In 2013 we acquired certain Camelina sativa (“Camelina”) assets that we have been developingas an ultra-low carbon non-food based feedstock for the production and sale of renewable fuels. Infeedstock. Between July 2018, the date that we entered into a letter of intent tofor the purchase of a 500-acre crude oil refinery in Bakersfield, California (the “Bakersfield Biorefinery”). Duringand the fiscal quarter ended June 30,closing of the purchase of the Bakersfield Biorefinery in May 2020, we were exclusively engaged in completing the purchase of the refinery and in obtaining the financing necessary purchase and retool the Bakersfield Biorefinery into a renewable fuels facility. Accordingly, our principal expenses during 2019 and continuing upuntil we purchased the Bakersfield Biorefinery in May 2020 consisted of general and administrative expenses and costs incurred to our acquisitionobtain the financing required to purchase and retool the Bakersfield Biorefinery. After the purchase of the Bakersfield Biorefinery on May 7, 2020, we incurred an increasing amount of general and administrativeboth our operating expenses and other preliminary acquisition costs expenses relatedour capital expenditures increased significantly.

Since all of our resources were dedicated to our efforts to acquirethe purchase and financing of the Bakersfield Biorefinery.

Biorefinery, we did not generate any operating revenues in either 2019 or 2020. In order to fund our operating and acquisition-related expenses in October of 2018during these periods, we entered intoobtained $6 million under a derivative contract (the “Derivative Contract”) that we entered into with a commodity trading company for the delivery of ultra-low sulfur renewable diesel for settlement over a six-month period beginninglate in July 2020. Under the Derivative Contract, we received $6 million in cash. At the inception of the Derivative Contract, we recorded a $15.1 million liability and $9.1 million of financing costs. During the remaining portion of 2018, the derivative liability decreased by $3.1 million.October 2018. In October 2019 we modified the Derivative Contract, entered into a new Derivative Contract, and received another $4 million in cash. The Derivative Contract was further amended in 2020 and replaced by a fixed payment obligation that requires the Company to make total payments of cash.$24.8 million, consisting of the $4.5 million payment we made in June 2020, and six equal monthly installment payments beginning in May 2022. The cash that we received from the Derivative Contract was used to fund our operating costs, our due diligence costs, our pre-acquisition costs, the purchase price down payment/deposit for the Bakersfield Biorefinery, our consulting and legal fees associated with the acquisition, and our payments to key vendors and suppliers. The Derivative Contract was amended in March 2020 and was converted into a fixed payment obligation. This fixed payment obligation was modified again in April 2020. Under the amended terms, the fixed payment obligation requires total payments of $24.8 million, including a payment of $4.5 million in June 2020, and six monthly installment payments beginning in May 2022.

 -22-

 

In May 2020 we completed the purchase of the Bakersfield Biorefinery. The total amount of cash consideration paid for the refinery was $40 million and the total amount of all consideration and assumed liabilities was $89.4 million. In order to fund the purchase price of the Bakersfield Biorefinery and the currently on-going conversion of the facility into a renewable diesel refinery, in May 2020 we also entered into a $300 million senior loan facility and a $65 million mezzanine loan facility. In November 2020 we added a total of $15 million to our credit facilities whereby as of December 31, 2020 our senior loan facility was $313.2 million, and our mezzanine loan facility was $66.8 million. We are currently converting the Bakersfield Biorefinery from a crude oil refinery into a biorefinery, and we do not expect to commence our proposed biofuel refinery operations until early 2022. Therefore, we do not anticipate generating revenues from the operations of the Bakersfield Biorefinery until the first half of 2022.

 -24-

We continue to contract with farmers for the planting of our Camelina certified seed for grain production for the 2021 crop year. As of April 30, 2021 we have contracted for cultivation of approximately 15,000 acres of our proprietary varieties of Camelina. We anticipate a significant ramp up of production of Camelina in 2022. We do expect to generate some revenues from Camelina seed sales to farmers in 2021, but that amount is not expected to be material. Additionally, we are strengthening our Camelina patent position by adding another six variety patents and seven utility patents and are continuing our gene editing program to improve the ultimate yields and oil composition of our patented Camelina varieties.

In order to havefurther strengthen our ability to produce genome edited, proprietary varieties of Camelina, seed and oil available when our biorefinery commences its refinery operations, and in order to have farmland under cultivation for future Camelina harvests,on April 15, 2021, we have started investing in farming activitiesacquired 100% of the outstanding equity of Agribody Technologies, Inc., a privately held agricultural biotechnology company that owns 16 patents related to our Camelina seed production. These activities include investments in growing certified seed for future plantings, paymentsthe use of genetics to farmers for growing Camelina for delivery to us, processing costsincrease yield, shelf life and other necessary costs associated with adding to oursustainability traits in Camelina seed, oil and meal inventories.many other crops. The acquisition was effected in an all-stock transaction for a total value of approximately $5 million. In consideration for the shares of Agribody Technologies, Inc. the Company issued 830,526 shares at an approximate value of $6.02 per share.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported assets, liabilities, sales and expenses in the accompanying financial statements. Critical accounting policies are those that require the most subjective and complex judgments, often employing the use of estimates about the effect of matters that are inherently uncertain.

 

The Company’s most critical accounting policies and estimates that may materially impact the Company’s results of operations include:

Capitalization of Pre-Acquisition CostsAsset Retirement Obligations. The Company capitalizes its pre-acquisition costs once management determinesrecognizes liabilities which represent the fair value of a legal obligation to perform asset retirement activities, including those that itare conditional on a future event, when the amount can be reasonably estimated. If a reasonable estimate cannot be made at the time the liability is probableincurred, we record the liability when sufficient information is available to estimate the liability’s fair value. We have asset retirement obligations with respect to our Bakersfield Biorefinery due to various legal obligations to clean and/or dispose of these assets at the time they are retired. However, the majority of these assets can be used for extended and indeterminate periods of time provided that the project will occur. Probabilitythey are properly maintained and/or upgraded. It is determinedour practice and intent to continue to maintain these assets and make improvements based on (i) whether management, having the requisite authority, has implicitly or explicitly authorized and committed to funding the acquisition or constructiontechnological advances. A portion of a specific asset, (ii) the financial resources are available consistent with such authorization, and (iii) the ability exists to meet the necessary local and other governmental regulations. Cost capitalization occurs when the event is probable, but priorthese obligations relate to the startrequired cleanout of construction.hydrocarbons previously used in the pipeline and terminal tanks. In order to determine the fair value of the obligations management must make certain estimates and assumptions including, among other things, projected cash flows, a credit-adjusted risk-free rate and an assessment of market conditions that could significantly impact the estimated fair value of the asset retirement obligations. We capitalize those costs that are directly identifiable withbelieve the specific property and those costs that would be capitalized ifestimates selected, in each instance, represent our best estimate of future outcomes, but the property were already acquired. We expense general and administrative and overhead costs and costs, including payroll, that would be considered support functions.actual outcomes could differ from the estimates selected.

 

Derecognition ofEnvironmental Remediation Liabilities. The Company reviewsrecognizes its asset retirement obligation and environmental remediation liabilities includingin accordance with ASC 410-30, and has estimated such liabilities as of its acquisition date. It is the Company’s policy to accrue environmental and clean-up related costs of a non-capital nature when it is both probable that a liability has been incurred and the amount can be reasonably estimated. Environmental remediation liabilities represent the current estimated costs to investigate and remediate contamination at our properties. This estimate is based on internal and third-party assessments of the extent of the contamination, the selected remediation technology and review of applicable environmental regulations, typically considering estimated activities and costs for 20 years, and up to 30 years if a longer period is believed reasonably necessary. Accruals for estimated costs from environmental remediation obligations generally are recognized no later than completion of the remedial feasibility study and include, but are not limited to, accounts payable, notes payable, accrued expenses, accrued liabilitiescosts to perform remedial actions and other legal obligations, for a determinationcosts of the legal enforcement or settlement of an obligation. Upon conclusive evidencemachinery and equipment that an obligation may be extinguished, has expired, is discharged, cancelled or otherwise no longer legally exists, then the Company will derecognize the respective liability on the Company's balance sheet.

Derivative Commodity Instruments. The Company uses derivative commodity instruments as a means of generating cash for its efforts in procuring a refinery to fulfill its business plan. The Company may use such instruments in the future to manage its exposures for its feedstocks or end products. Normal purchases and normal sales are contracts that provide for the purchase or sale of something other than a financial instrument or derivative instrument that will be delivered in quantities expected to be used or sold over a reasonable period in the normal course of business. While the Company may deliver refined products from its biorefinery in the future, at this time these derivative contracts are not considered normal sales contracts. The results of our derivative activities were materialdedicated to the Company’s financial position,remedial actions and that do not have an alternative use. Such accruals are adjusted as further information develops or circumstances change. We discount environmental remediation liabilities to their present value if payments are fixed and determinable. Expenditures for equipment necessary for environmental issues relating to ongoing operations are capitalized. Changes in laws and regulations and actual remediation expenses compared to historical experience could significantly impact our results of operations or cash flowsand financial position. We believe the estimates selected, in 2019 and 2020. The Company’s risk management practices and its compliance with policies are reviewed byeach instance, represent our best estimate of future outcomes, but the Company’s Board of Directors. Derivatives beyond those designated as normal purchase and normal sale contracts are recorded at fair value onactual outcomes could differ from the Consolidated Balance Sheet with resulting gains and losses reflected in income. Fair values are derived principally from published market quotes and other independent third-party quotes. The change in fair value of Company’s derivative commodity instruments in 2019 and 2020 was material to the Company’s results of operations.estimates selected.

 

 -25-

Recoverability of Intangible Assets. The Company invests in the development of various plant-based feedstocks for conversion to fuel as part of its core business plan.plan and mandate. The Company has purchased patents and associated know-how that relate directly to the development and growing of Camelina. The Company invests in the ongoing development of Camelina

 -23-

through research and additional patents as breakthroughs occur. The Company capitalizes all of its patent expenses and amortizes these costs over aan approximate 17-year period in conjunction with the life of the patent protection. As part of the Bakersfield Biorefinery we acquired certain operational permits which we amortize over an estimated life of 15 years. We evaluate the carrying costs of these assets on a periodic basis and will impair such value if deemed necessary. As of June 30, 2020,March 31, 2021, no impairment is necessary and the carrying value of our intangible assetsintellectual property (intangible assets) remains a significant value and expected economic generator going forward.

  

Certain other critical accounting policies, including the assumptions and judgments underlying them, are disclosed in Note 1 to the Consolidated Financial Statements included in theCompany’s Annual Report filed on Form 10-K for the year ended December 31, 2019 that the Company has filed with the Securities and Exchange Commission.SEC. However, we do not believe that there are any alternative methods of accounting for our operations that would have a material effect on our financial statements.

 

Results of Operations

Three Months Ended June 30, 2020March 31, 2021 vs. Three Months Ended June 30, 2019March 31, 2020

Revenues. As discussed above, during 2019the first quarter of 2020 and continuing until we purchased the Bakersfield Biorefinery on May 7, 2020, our activities were devoted solely to the acquisition and financing of the Bakersfield Biorefinery. Therefore, we had no operating revenues in the fiscal quarter ended March 31, 2020 (the “2020 fiscal quarter”). Following the acquisition, we refocusedfocused our efforts on building our operations and management teams necessary and on putting the processes in place to accomplish the task of retrofitting the Bakersfield Biorefinery and weBiorefinery. We did not engage in any operating activities that generated revenues.revenues until the first quarter of 2021 when we started selling our Camelina seeds to farmers for the production of Camelina seed and grain for our Bakersfield Biorefinery. Therefore, we had no operating revenues from the Bakersfield Biorefinery in the fiscal quarters ended June 30, 2019March 31, 2021 (the “2019“2021 fiscal quarter”) or June 30, 2020 (the “2020 fiscal quarter”)and only a minimal amount of seed revenues, ($0.1 million).

 

General And Administrative Expenses and Facility Expenses. Expenses. General and administrative expense consists of expenses generally involving corporate overhead functions and operations. OurIn the 2020 fiscal quarter, we did not own the Bakersfield Biorefinery and, as a result, we had fewer overhead expenses. In the 2021 fiscal quarter, we owned the Bakersfield Biorefinery and, therefore, had significantly higher expenses, including higher employment, facilities, insurance, legal, and general andoverhead expenses. As a result our administrative expenses increased by $0.9$3.4 million or 100%, from $0.9$0.3 million in the 20192020 fiscal quarter to $1.8$3.7 million in the 20202021 fiscal quarter. This increase was primarily related to an increase in overall payroll costs and benefits, professional fees, legal feesinsurance costs, technology and communications costs and various vendor costs. In the period after we acquired the Bakersfield Biorefinery on May 7, 2020,We anticipate that our general and administrative expenses increased significantly, and these expenses are expected towill continue to increase as the development of the refinery progresses.progresses and operations commence. Facility expense primarily consists of maintenance costs to keep the Bakersfield assets, purchased in May 2020, in an operational mode and expenses normally related to operations.the operations of a refinery. Our facility expenses were $0.7$2.8 million in the 20202021 fiscal quarter and we incurred no such expenses in the 20192020 fiscal quarter.

 

Other Income/Expense. In the 20202021 fiscal quarter we had no impact from derivatives, whereas in the 20192020 fiscal quarter we incurredrecognized $5.5 million of income from the decrease in fair value on a $1.3derivative contract and a gain of $0.5 million gain from ouron the derecognition of the Derivative Contract. In the 2021 fiscal quarter we recognized a charge of $0.9 million on the change in derivative liability.fair value of our Class B Units and we had no such charge in the 2020 fiscal quarter.

 

Interest Income/Expense. Interest expense in the 20202021 fiscal quarter and the 20192020 fiscal quarter consisted of interest of $0.8$0.7 million and $0.1$0.2 million, respectively, from outstanding promissory notes and discount on our notes payable.notes. Our incurred interest will increase significantly in the future as we draw down on the $300$313.2 million senior and $65$66.8 million mezzanine loans, and as the outstanding principal balances of those loans increases. However, construction period interest will be capitalized as part of the cost of the refinery and will be depreciated, and therefore, will not impact our interest expense.

 

Net losses. We incurred an operating loss of $2.7$6.7 million and $1.1$0.4 million in the 20202021 and 20192020 fiscal quarters respectively. We incurred a net loss of $3.4million$8.2 million in the 20202021 fiscal quarter compared to a $0.2$5.4 million net income in the 20192020 fiscal quarter. Our operating loss increased becauseas a result of the increase in activity related to our purchase of the Bakersfield Biorefinery. We expect to incur losses for the remainder of 2020 and 2021 while our biorefinery is under construction and therefore not operational.

Six Months Ended June 30, The lower operating and net losses in fiscal 2020 vs. Six Months Ended June 30, 2019quarter were the result of one-time non-cash accounting adjustments to recognize the gains attributable to the change in the fair value of the Derivative Contract and the derecognition of that contract.

  

 -24--26-

Revenues. As discussed above, during 2019 and during most of the second quarter of 2020, our activities were devoted solely to the acquisition and financing of the Bakersfield Biorefinery, which acquisition was completed on May 7, 2020. Because we were focused on purchasing, and thereafter retrofitting, the Bakersfield Biorefinery during 2019 and 2020, we did not engage in any operating activities that generated revenues. Therefore, we had no operating revenues in the six months ended June 30, 2019 (the “2019 fiscal period”) or June 30, 2020 (the “2020 fiscal period”).

General And Administrative Expenses and Facility Expenses. Our general and administrative expenses increased by $0.1 million, or 5%, from $2.0 million in the 2019 fiscal period to $2.1 million in the 2020 fiscal period This increase was primarily related to an increase in payroll costs, professional fees, legal fees and various vendor costs. Since we acquired the Bakersfield Biorefinery in May 2020, our general and administrative expenses have increased in the second half of 2020 and are expected to continue to increase as the development of the refinery progresses. Our facility expenses were $0.8 million in the 2020 fiscal period and we incurred no such expenses in the 2019 period.

Other Income/Expense. In the 2020 fiscal period we had net income of $5.0 million compared to a net expense of $2.8 million in the 2019 fiscal period. In the 2020 fiscal period we generated a $5.5 million gain on the change of our derivative liability and a gain of $0.5 million on the settlement of the derivative liability compared to the 2019 fiscal period in which we incurred a $2.6 million charge due to a change in our derivative liability.

Interest Income/Expense. Interest expense in the 2020 fiscal period and the 2019 fiscal period consisted of interest of $0.9 million and $0.2 million, respectively, from outstanding promissory notes and discount on our notes payable. Our incurred interest will increase significantly in the future as we draw down on the $300 million senior and $65 million mezzanine loans, and as the outstanding principal balances of those loans increases. As referenced above, our construction period interest will be capitalized.

Net Income/Losses. For the 2020 fiscal period, we had net income of $2.0 million compared to a net loss of $5.9 million in the 2019 fiscal period. Our net income was primarily generated by our $6.0 million gain resulting from the change in our derivative liability and the gain on the settlement of liabilities. We expect to incur losses for the remainder of 2020 and 2021 while our biorefinery is under construction and therefore not operational.

Liquidity and Capital Resources

As of June 30,March 31, 2021 and 2020, and 2019, we had approximately $7.2$35.7 million (of which $3.9 million was unrestricted) and $0.5$0.1 million of cash, respectively, of which $20.8 million is considered long-term as that cash is more likely to be spent on the construction project and awill be capitalized into the project as spent. On March 31, 2021 we had negative working capital of $0.2$13.8 million and $33negative working capital of $12.4 million at the end of March 31, 2020, respectively. However, of the $7.2$35.7 million of cash as of March 31, 2021, only $3.9$3.1 million is unrestricted and available to pay our current liabilities, while the remaining $3.3$32.6 million of cash is restricted and can only be used to fund our senior loan interest obligations and our biorefinery construction costs.

In order to fund some of our working capital expenses, on April 13, 2021, the Company raised $3.1 million through the sale of 496,000 shares at $6.25 per share to three accredited investors. In connection with the foregoing sale of shares, we also issued to the investors warrants for the purchase of 19,840 shares (which warrants have an exercise price of $6.25).

Our efforts to acquire the Bakersfield Biorefineryrefinery commenced in early 2018. Our operating costs, including the costs of the professionals that we engaged, exceeded our capital resources. Accordingly, on October 15, 2018, we entered into a derivative contract with a commodities trading company whereby we received $6 million of cash in exchange for a contract for ultra-low sulfur diesel to be settled over a six-month time period beginning in July of 2020. This contract created a net fair value liability of $15.1 million. The purpose of this contract was to obtain the cash the Company needed to pursue the acquisition of the Bakersfield Biorefinery. The liability in excess of cash received is considered financing charges and recorded as an expense. Because of a delay in completing the purchase of the Bakersfield Biorefinery, we had to amendWe subsequently unwound the original derivative contract. Accordingly,contract on October 29, 2019 we unwound the October 15, 2018 contract and entered into a new derivative transaction whereby we received an additional cash payment of $4 million. On March 19, 2020 we unwound theThe new derivative contract was amended again on April 20, 2020 and fixed the obligation withcalled for a cash payment of $5.5 million due on April 30th and six equal monthly payments of $2.928 million beginning on October 31, 2021. On April 28, 2020 this agreement with the commodities trading company was amended in terms to reduce and extend the short-term cash payment to $4.5 million in June 2020 (that we paid) and increased and deferred the six equal monthly payments of $3.375 million beginning on April 30,in May 2022. This payment stream is scheduled to coincide around the commencement of operations and the resulting cash flow of the Bakersfield Biorefinery.

 -25-

 

The Bakersfield Biorefinery is currently being retooled and converted from a crude oil refinery into a biofuels refinery. The construction of the Bakersfield Biorefinery is expected to be completed, and the Bakersfield Biorefinery is expected to commence commercial operations in early 2022. Until the Bakersfield Biorefinery is operational, we dowill not expect to generate any significantrefinery operating revenues. We anticipate that we will generate some revenues in 2021 from sales of Camelina seed, although such revenues are not expected to be significant. During the construction phase of the biorefinery, we will incur significant operating costs and capital expenditures to upgrade the existing equipment and facilities. The expenses that we expect to incur include, among others, the purchase price of new biorefinery equipment, the payments to our primary contractorcontractors under a $201 millionthe various engineering, procurement and construction agreement,agreements that we entered into, the costs of maintaining the existing facility during the construction phase, paying licensingengineering fees and payroll costs, the costs of upgrading the refinery’s rail line and certain pipelines, and making interest and other payments under our senior and mezzanine credit facilities.

In order to fund the cost of acquiring the Bakersfield Biorefinery, converting the existing refinery into a biorefinery, and paying all operating expenses during the preoperational period, in May 2020 we entered into (i) a $300 million senior secured term loan facility with certain senior lenders which credit facility was upsized to $313.2 million in November 2020, and (ii) a $65 million secured term loan facility with various mezzanine lenders. Our senior andcertain mezzanine lenders havewhich was also recently agreedupsized to make an additional $15$66.8 million available to us, if requested, to develop the Bakersfield Refinery and our feedstock program.in November 2020. As of November 30, 2020,March 31, 2021, we have borrowed $151$182.4 million under the senior credit facility, of which approximately $65$43 million is unspent;was unspent as of the end of March 31, 2021. As of March 31, 2021, we have not yet utilized the mezzanine credit facility or the additional $15 million of available credit.facility.

 -27-

The senior loancredit facility bears interest at the rate of 12.5% per annum, payable quarterly. No principal payments are required to be made under the senior loan until maturity. The senior loan matures on November 4, 2026. The mezzanine loan will bear interest at the rate of 15.0% per annum on amounts borrowed, payable quarterly, provided that we may defer up to 2.5% interest to the extent we do not have sufficient cash to pay the interest (any deferred interest will be added to principal). Principal of the mezzanine loans is due at maturity. As additional consideration for the senior loans and mezzanine loans, the senior lenders were issued Class B units (and the mezzanine lenders will be issued Class C Units when we borrow under the mezzanine loans) in our subsidiary that indirectly owns the Bakersfield Biorefinery. The Class B and C Units will not affect our liquidity until the Bakersfield Biorefinery commences operations in 2022. However, since the holders of the Class B and C Units will be entitled to certain priority cumulative distributions, if any, that may be made in the future from the operations of the Bakersfield Biorefinery, distributions made on behalf of the Class B and C Units will reduce the amount of distributions that we may be entitled to receive in the future from the operations of the Bakersfield Biorefinery.

Based on our construction budget (including the purchase orders we have issued for the required equipment) and on our internal projections of our future operating expenses, we anticipateanticipated that the $365$380 million available to us under the senior and mezzanine loans should be sufficient to fund our original projected capital expenditures and operating expenses at the Bakersfield Biorefinery until the Bakersfield Biorefinery becomes operational. AlthoughHowever, the scope of the Bakersfield Biorefinery has both changed and expanded to include additional capabilities and equipment, which changes are expected to increase the cost of installing, developing and constructing the Bakersfield Biorefinery. In order to be prepared for cost overruns and the additional facility investments, we have agreed with our senior and mezzanine lenders to establish a $35 million contingency reserve by July 31, 2021 to fund such costs. We currently do not have the funds provided underto establish the contingency reserve and will, therefore, have to raise this amount through a public or private sale of our securities or from other arrangements. No assurance can be given that we will be able to raise the funds by July 31, 2021, or at all. A portion of GCEH’s corporate overhead has been funded from the senior and mezzanine loans may only be used forloan advances, which advances GCEH has agreed to pay to the Bakersfield refinery and servicing these debt obligations, since we share facilities and personnel, we will realize a reduction in certain of our operating expenses. We believe that these cost savings, plus our other financial resources should be sufficient to fund our operations through the commercial start-up of the Bakersfield Biorefinery.

Our transition to profitability is dependent upon, among other things, the successful and timely development and construction of our biorefinery and the future commercialization of the products that we intend to produce at the Bakersfield Biorefinery. In order toTo ensure that we have a buyer for the renewable diesel produced at our biorefinery, we have entered into an offtake agreement with ExxonMobil Oil Corporation.Corporation (ExxonMobil). Under that agreement, ExxonMobil has agreed to purchase a minimum of 852.5 million gallonsbarrels per year of renewable diesel from the Bakersfield Biorefinery for a period of five years following the date that the Bakersfield Biorefinery commences commercial operations, with the right to acquire additional volumes. The Bakersfield Biorefinery is being designed for a capacity of 15,000 barrels per day or an annual volume of approximately 5.4 million barrels per year. On April 20, 2021 we entered into a second agreement, a term purchase agreement, with ExxonMobil whereby ExxonMobil has the right to purchase additional quantities of renewable diesel above the original 2.5 million barrels per year. The revenues we expect to receive under the offtake agreement and the term purchase agreement, together with our other projected sources of revenues, are expected to fund our anticipated working capital and liquidity needs.

 -26-

Once completed, the Bakersfield Biorefinery will be able to produce renewable diesel from various renewable feedstocks, such as Camelina oil produced from our patented Camelina varieties, soybean oil, used cooking oil, inedible animal fat, and other vegetable oils. We believe that one of our strategic advantages is that a significant portion of the feedstock expected to be used at our biorefinery will be Camelina grain produced by third party farmers for usthe Bakersfield Biorefinery using our patented Camelina varieties. However, we anticipate that we will need additional funding for general corporate purposes and to grow our certified Camelina seeds, to enter into agreements with farmers, and to otherwise ramp up the cultivation and production of Camelina. As of the date of this report, we have only secured limited funding for our Camelina production plans. Although we are currently in discussions with certain agri-finance companies, other strategic partners, our existing lenders, investment bankers and possible third party investors for debt or equity financing for our Camelina operations and for general corporate purposes, no assurance can be given that we will obtain the necessary funds, or that if we do obtain such funding, that the terms under which we obtain such funding will be beneficial to us.

To the extent that we raise additional funds by issuance of equity securities, our stockholders would experience further dilution and the terms of these securities could include liquidation or other preferences that would adversely affect our stockholders’ rights. Our ability to secure additional equity financing could be significantly impacted by numerous factors including our the status, timing and cost of the conversion of the Bakersfield Biorefinery, positive or negative developments in the environmental regulations and the demand for biofuels, and general market conditions, and there can be no assurance that we will successful in raising capital or that any such financing will be available, available on favorable or acceptable terms or at the times, or in the amounts needed. Additionally, while the potential economic impact brought on by and the duration of the coronavirus pandemic is difficult to assess or predict, the significant impact of the coronavirus pandemic on the global financial markets, and on our own stock trading price, may reduce our ability to access additional capital, which would negatively impact our short-term and longer-term liquidity.

Inflation and changing prices have had nominimal effect on our continuing operations over our two most recent fiscal years.

We have no off-balance sheet arrangements as defined in Item 303(a) of Regulation S-K.

 -28-

Item 3. Quantitative and Qualitative Disclosures about Market Risk

NothingAs a “smaller reporting company” as defined by Item 10 of Regulation S-K promulgated by the SEC under the U.S. Securities Act of 1933, as amended, we are not required to report.provide the information required by this Item 3.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) that are designed to assure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and our Chief Financial Officer (the “Certifying Officers"), as appropriate, to allow timely decisions regarding required disclosures.

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide reasonable assurance only of achieving the desired control objectives, and management necessarily is required to apply its judgment in weighing the costs and benefits of possible new or different controls and procedures. Limitations are inherent in all control systems, so no evaluation of controls can provide absolute assurance that all control issues and any fraud within the company have been detected.

 

As required by Exchange Act Rule 13a-15(b), as of the end of the period covered by this Quarterly Report on Form 10-Q, management, under the supervision and with the participation of our Certifying Officers, evaluated the effectiveness of our disclosure controls and procedures. Based on this evaluation, the Certifying Officers have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were, based on the Framework of Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) 2013, not effective because of the following material weaknesses in our internal control over financial reporting: (i) Asineffective controls over period end financial disclosure and reporting processes, including not timely performing certain reconciliations, and lack of June 30, 2020 we did not have sufficient accounting staff ,approval of adjusting journal entries, and (ii) as of June 30, 2020 there was insufficient segregation of duties relatedthe Company has not performed a risk assessment and mapped the accounting processes to processing, approving and reviewing transactions and journal entries.control objectives. We have taken remedial steps to address the material weaknesses in our disclosure controls and procedures. These remedial steps include the following:

 

 -27-

(a) Since June 30, 2020, we haveThe Company has hired (i) a staff accountantadditional financial and accounting personnel who are experienced in U.S. GAAP financial reporting. The Company is also is a CPA, and (iv) other members of a newly established clerical department;evaluating its accounting personnel as necessary to remediate the identified weaknesses;

 

(b) We began developing the accounting processes necessary to achieve effective controls, including more segregation of duties as our personnel allows;

(c) We have designed and areThe Company is implementing more robust financial reporting, accounting and management controls over ourits accounting and financial reporting functions, at our two facilities.including developing and implementing a supplemental approval procedure for costs and expenses in excess of budgeted line items. The Company continues to evaluate and modify, as necessary, its approval control procedures;

(c) The Company has engaged, and will continue to engage, the necessary independent experts to assist the Company in improving its internal control over financial reporting.

 

Except as described above, there has been no change in the Company’s internal control over financial reporting during the quarter ended June 30, 2020March 31, 2021 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 -29-

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On August 24, 2020 Wood Warren & Co Securities, LLC filed a complaintThe information required with respect to this item can be found under “Legal” in Note H to our condensed consolidated financial statements included elsewhere in this Form 10-Q and is incorporated by reference into this Item 1.

In the future, we may become party to legal matters and claims arising in the Superior Courtordinary course of California, Alameda County, against GCE Holdings Acquisitions, LLC titled “Wood Warren & Co Securities, LLC vs. GCE Holdings Acquisitions, LLC” (Case No. RG 20072242). The complaint alleges that GCE Holdings Acquisitions, LLC breached that certain Consulting Agreement, dated October 8, 2019, by failing to pay Wood Warren & Co Securities, LLC certain fees that Wood Warrant claims it has earned underbusiness, the Consulting Agreement. Wood Warren & Co Securities, LLC has asked the court for an awardresolution of $1.2 million. On October 14, 2020, GCE Holdings Acquisitions, LLC filed an answer and denied all allegations in the complaint.which we do not anticipate would have a material adverse impact on our financial position, results of operations or cash flows.

Item 1A. Risk Factors

The discussion of our business and operations should be read together with the risk factors contained in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 20192020 filed with the SEC, which describe various risks and uncertainties to which we are or may become subject. These risks and uncertainties have the potential to affect our business, financial condition, results of operations, cash flows, strategies or prospects in a material and adverse manner.

 

Uncertain Impact of Covid-19 CoronavirusCOVID-19. The outbreakIn December 2019, a novel strain of coronavirus (also known as COVID-19)diseases (“COVID-19”) was first reported in Wuhan, China. Less than four months later, on March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. The extent of COVID-19’s effect on the Company’s operational and financial performance is ongoing but the Company believes that this particular pandemic is not likely to be materially disruptive to its future plans and targeted date of beginning commercial operations. While the Company has implemented strict protocols on its on-site workforce and continues to monitor the potential impacts to its business. The Company has implemented strict protocols on its on-site workforce and continues to monitor the potential impacts to its business. While the Company expects that the future impacts due to COVID-19 are not currently nor expected to materiallybe disruptive to its ongoing business, the impact our operations unless our workforce or ourof COVID-19 on the economy, its industry, and on the Company’s contractors cannotand subcontractors are constantly evolving, and the future effects continue the developmentto be highly uncertain and construction of the Bakersfield Biorefinery. We are committed to ensuring the safety of our personnel, consultants and vendors who must work on site. There is no assurance that we will not have a COVID-19 exposure that may cause material delays in the development and/or commencement of commercial operations of the Bakersfield Biorefinery. Any material delay in completing the construction of the Bakersfield Biorefinery or commencing its operations could have a material negative impact on our future operations, cash flow and financial condition.unpredictable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On April 29, 2020, an independent contractorMarch 26, 2021, we issued 1,586,786 shares of the Company purchased 750,000 sharesCompany’s common stock to the holder of Common Stocka convertible promissory note upon the exercise of a stock option. The exercise price was $0.0056 per share.

On May 6, 2020, an executive officerconversion of the Company purchased 5,542,857 shares of Common Stock uponentire outstanding balance, principal and accrued interest, for that note which was $476,036. The issuance was exempt from the exercise of a stock option. The exercise price averaged approximately $0.0027 per share.

 -28-

All of the foregoing securities were issued in reliance upon the exemption from registration provided by Section 4(a)(2)requirements of the Securities Act of 1933, as amended, (the “Securities Act”) or Regulation D underpursuant to Section 4(a)(2) of the Securities Act.act applicable to a transaction by an issuer not involving a public offering of securities. No broker-dealers were usedunderwriter was involved in connection with such salesthe issuance of unregistered securities.the shares.

 

Item 3. Defaults upon Senior Securities

 

Nothing to report.

 

Item 4. Mine Safety Disclosures

 

Nothing to report.

 -30-

Item 5. Other Information

 

NothingEngineering, Procurement and Construction Agreement

On May 18, 2021 our Bakersfield Renewable Fuels, LLC subsidiary and CTCI Americas, Inc., a Texas corporation (“CTCI”), entered into that certain Turnkey Agreement with a Guaranteed Maximum Price for the Engineering, Procurement and Construction of the Bakersfield Renewable Fuels Project (the “CTCI EPC Agreement”). CTCI Americas is a worldwide leading provider of reliable engineering, procurement and construction services, including for the refinery market. Under the CTCI EPC Agreement, CTCI has agreed to report.provide services to complete the engineering, procurement, construction, pre-commissioning, commissioning, start-up and testing of our renewable diesel production facility under construction in Bakersfield, California. The CTCI EPC Agreement requires the Bakersfield Biorefinery to be substantially complete, and to be ready for commercial operations, on January 22, 2022. CTCI’s fees and costs, including direct costs, overhead fees and the contractor’s fee, are guaranteed not to exceed $178 million (which maximum price is subject to adjustment for certain change orders). The obligations of CTCI have been guaranteed by CTCI Corporation, the Taiwanese parent company of CTCI.

Termination of ARB, Inc. EPC Agreement

ARB Inc. has been the primary contractor for the Bakersfield Biorefinery and has operated under that certain Turnkey Agreement with a Guaranteed Maximum Price for the Engineering, Procurement and Construction of the Bakersfield Renewable Fuels Project, dated as of April 30, 2020 (the “ARB EPC Agreement”). On May 19, 2021 we notified ARB, Inc. that we were terminating the ARB EPC Agreement, effective immediately. The subcontracts for the Bakersfield Biorefinery were not terminated and are being subsumed in the CTCI EPC Agreement. Accordingly, the subcontractors will continue to provide their services for the Bakersfield Biorefinery through CTCI.

Amendment to Credit Agreement

Certain of our subsidiaries, including Bakersfield Renewable Fuels, LLC, were parties to a Credit Agreement, dated May 4, 2020, with a group of lenders (the "Senior Lenders") under which the Senior Lenders have agreed to provide our subsidiaries with a $313.2 million senior secured term loan facility (the foregoing agreement, as amended to date, is herein referred to as the “Credit Agreement”). On May 18, 2021 we entered into Amendment No. 4 to Credit Agreement (the “Amendment”) with the Senior Lenders. The Amendment was entered into primarily to consent to the replacement of the ARB EPC Agreement with the CTCI EPC Agreement. Concurrently with the execution of the Amendment, the lenders under the $66.8 million mezzanine credit facility (none of which has yet been used) also entered into a consent and waiver agreement to evidence their consent to the replacement of the ARB EPC Agreement with the CTCI EPC Agreement.

 -31-

Item 6. Exhibits

 

Exhibit  
Number Description
10.1

Term Purchase Agreement, dated April 20, 2021 between Bakersfield Renewable Fuels, LLC and ExxonMobil Oil Corporation*

10.2Amendment No. 4 to Credit Agreement, dated as of May 18, 2021, between BKRF OCB, LLC, BKRF OCP, LLC, and the senior lenders referred to therein*
10.3Turnkey Agreement with a Guaranteed Maximum Price for the Engineering, Procurement and Construction of the Bakersfield Renewable Fuels Project, dated May 18, 2021, between Bakersfield Renewable Fuels, LLC and CTCI Americas, Inc.*
   
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS XBRL Instance Document.
   
101.SCH XBRL Taxonomy Schema.
   
101.CAL XBRL Taxonomy Extension Calculation Linkbase.
   
101.DEF XBRL Taxonomy Extension Definition Linkbase.
   
101.LAB XBRL Taxonomy Extension Label Linkbase.
   
101.PRE XBRL Taxonomy Extension Presentation Linkbase.

 ____________________________
* Certain confidential portions of this Exhibit were omitted by means of marking such portions with an asterisk because the identified confidential portions are (i) not material and (ii) would be competitively harmful if publicly disclosed.

 -29--32-

SIGNATURES

 

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 
GLOBAL CLEAN ENERGY HOLDINGS, INC.
   
Date: December 10, 2020May 20, 2021By:  /s/ Richard Palmer
 

Richard Palmer

President and Chief Executive Officer

Date: December 10, 2020May 20, 2021By:/s/ Ralph Goehring
 

Ralph Goehring

Chief Financial Officer

 

 -30--33-